Ohio State Navbar

Directory

Steven Devine, MD


Staff photo

320 W 10th Ave
Columbus, OH 43210

Phone: (614) 293-5655

Email: devine.54@osu.edu

 

Current OSU Appointments

Professor, Hematology

Physician, FGP-Hematology

 

Licenses

1990 - present Diplomate: American Board of Internal Medicine
1993 - present Diplomate: American Board of Internal Medicine
 

Chapters in Books

Wingard JR, Seay T, Devine SM.. "Hematological malignancies." In Medical Management of the Surgical Patient. 3rd ed. Edited by Lubin MF, Walker HK, Smith RB. -. New York: JB Lippincott, January 1993.

Devine SM, Hoffman R.. "Non-human Primate Models of Stem Cell Transplantation." In Allogeneic Stem Cell Transplantation. 1st ed. Edited by Laughlin MJ, Lazarus HM. -. Totowa, NJ, US|USA: Humana Press, January 2003.

Devine SM. "Novel Approaches to Stem Cell Mobilization." In Allogeneic Stem Cell transplantation, 2nd Edition. Edited by Lazarus H, Laughlin M. -. Totowa, NJ: Humana Press, January 2009.

Hamadani M, Devine SM. "Patient Evaluation Before Transplantation." In Hematopoietic Stem Cell Transplantation: A Handbook for Clinicians. Edited by Gastineau DA, Leather HL, Snyder E, Szczepiorkowski AM. -. Totowa, NJ: Humana Press, January 2009.

 

Clinical Services

08/01/2012 BMT Inpatient Service (James Cancer Hospital)
01/01/2013 BMT Inpatient Service (James Cancer Hospital)

Degrees

1983 A.A.S., Boston College

1987 B.A., University of Massachusetts

 

Editorial Activities

present Leukemia
present Leukemia and Lymphoma
2007 Haematologica
2007 Gene Therapy
2007 Nature Medicine
2007 Blood
2007 Experimental Hematology
2007 Journal of Hematotherapy
2007 Bone Marrow Transplantation
2007 Journal of Clinical Oncology
2007 Biology of Blood and Marrow Transplantation
2009 - present American Society of Hematology
2009 - 2005 American Society Hematology
2010 - present Biology of Blood and Marrow Transplantation
 

Honors

1982 Alpha Sigma Nu. Boston College.
1983 Phi Beta Kappa. Boston College.
1987 Alfred Pick Award for Academic Excellence. University of Massachusetts Medical School.
2000 Best Abstract, First Annual Mesenchymal Stem. international Society of Cellular Therapy.
2001 Cell Symposium Plenary Session Abstract Presenter, International. International Society of Cellular Therapy.
2005 - present Best Abstract Session, International Society of Cellular Therapy.
2007 - present America's Best Doctors. U.S. News & World Report.
2007 - 2009 "Top Docs" in US.
2008 - present ASBMT Board of Directors.
2008 - 2010 Voted as one of the "Best Doctors" in Columbus.
2009 - present NCI Clinical Investigator Team Leadership Award. National Cancer Institute.
2009 - present Bertha Bouruncle Faculty Teaching Award. Internal Medicine/Division of Hematology and Oncology.
 

Journal Articles

Devine SM, Vokes EE, Weichselbaum RR. "Chemotherapeutic and biologic radiation enhancement." Curr Opin Oncol. Vol. 6, no. 3. (January 1991.): 1087-1095.

b>Devine SM,/b>, Vokes EE, Weichselbaum RR. "Chemotherapeutic and biologic radiation enhancement.." Current Opinion in Oncology. Vol. 3, no. 6. (January 1991.): 1087-95.

Myers,S,E; Devine,S,M; TOPPER,R,L; ONDREY,M; Chandler,C; OTOOLE,K; Williams,S,F; Larson,R,A; Geller,R,B. "A PILOT-STUDY OF PROPHYLACTIC AEROSOLIZED AMPHOTERICIN-B IN PATIENTS AT RISK FOR PROLONGED NEUTROPENIA." LEUKEMIA & LYMPHOMA. Vol. 8, no. 3. (October 1992.): 229-233.

Thirman,M,J; Devine,S,M; OTOOLE,K; Cizek,G; Jessurun,J; Hertz,M; Geller,R,B. "BRONCHIOLITIS OBLITERANS ORGANIZING PNEUMONIA AS A COMPLICATION OF ALLOGENEIC BONE-MARROW TRANSPLANTATION." BONE MARROW TRANSPLANTATION. Vol. 10, no. 3. (September 1992.): 307-311.

Geller,R,B; Myers,S; Devine,S; Larson,R,A; Williams,S,F; Park,C,L; OTOOLE,K; Chandler,C; TOPPER,R,L. "PHASE-I STUDY OF BUSULFAN, CYCLOPHOSPHAMIDE, AND TIMED SEQUENTIAL ESCALATING DOSES OF CYTARABINE FOLLOWED BY BONE-MARROW TRANSPLANTATION." BONE MARROW TRANSPLANTATION. Vol. 9, no. 1. (January 1992.): 41-47.

Thirman MJ, Devine SM, O'Toole K, Cizek G, Jessurun J, Hertz M, Geller RB. "Bronchiolitis obliterans organizing pneumonia as a complication of allogeneic bone marrow transplantation.." Bone Marrow Transplantation. Vol. 10, no. 3. (January 1992.): 307-11.

Myers SE, Devine SM, Topper RL, Ondrey M, Chandler C, O'Toole K, Williams S F, Larson RA, Geller RB. "A pilot study of prophylactic aerosolized amphotericin B in patients at risk for prolonged neutropenia.." Leukemia & lymphoma. Vol. 8, no. 3. (January 1992.): 229-33.

Haraf D J, Devine SM,Ihde DC, Vokes EE. "The evolving role of systemic therapy in carcinoma of the lung.." Seminars in Oncology. Vol. 19, (January 1992.): 72-87.

Geller RB, Myers S, b>Devine SM,/b>, Larson RA, Williams S F, Park C L, O'Toole K, Chandler C, Topper RL. "Phase I study of busulfan, cyclophosphamide, and timed sequential escalating doses of cytarabine followed by bone marrow transplantation.." Bone Marrow Transplantation. Vol. 9, no. 1. (January 1992.): 41-7.

Devine SM, Geller RB, Holland HK, Wingard JR, Saral, R. "New preparative regimens with diaziquone or cytarabine in combination with busulfan and cyclophosphamide.." Seminars in Oncology. Vol. 20, (January 1993.): 56-63.

b>Devine SM,/b>, Larson RA. "Acute leukemia in adults: recent developments in diagnosis and treatment.." CA: A Cancer Journal for Cinicians. Vol. 44, no. 6. (January 1994.): 326-52.

Devine,S,M; Larson,R,A. "ACUTE-LEUKEMIA IN ADULTS - RECENT DEVELOPMENTS IN DIAGNOSIS AND TREATMENT." CA-A CANCER JOURNAL FOR CLINICIANS. Vol. 44, no. 6. (November 1994.): 326-352.

Devine SM,Wingard JR. "Viral infections in severely immunocompromised cancer patients.." Supportive Care in Cancer. Vol. 2, no. 6. (January 1994.): 355-68.

Nolte FS, Emmens RK, Thurmond C, Mitchell PS, Pascuzzi C, Devine SM,Saral R, Wingard JR. "Early detection of human cytomegalovirus viremia in bone marrow transplant recipients by DNA amplification.." Journal of Clinical Microbiology. Vol. 33, no. 5. (January 1995.): 1263-6.

Dix SP, b>Devine SM,/b>, Geller RB, Wingard JR. "Re: Severe interaction between methotrexate and a macrolide-like antibiotic.." Journal of the National Cancer Institute. Vol. 87, no. 21. (January 1995.): 1641-2.

Nolte,F,S; EMMENS,R,K; Thurmond,C; Mitchell,P,S; PASCUZZI,C; Devine,S,M; SARAL,R; Wingard,J,R. "EARLY DETECTION OF HUMAN CYTOMEGALOVIRUS VIREMIA BONE-MARROW TRANSPLANT RECIPIENTS BY DNA AMPLIFICATION." JOURNAL OF CLINICAL MICROBIOLOGY. Vol. 33, no. 5. (May 1995.): 1263-1266.

Gharpure VS, Devine SM, Holland HK, Geller RB, O'Toole K, Wingard J R. "Thrombotic thrombocytopenic purpura associated with FK506 following bone marrow transplantation.." Bone Marrow Transplantation. Vol. 16, no. 5. (January 1995.): 715-6.

Fay JW, Nash RA, Wingard JR; Przepiorka D, Collins RH, Anasetti C, Devine SM, Pineiro LA, Storb RF, Aro RM. "FK 506-based immunosuppression for prevention of graft versus host disease after unrelated donor marrow transplantation.." Transplantation Proceedings. Vol. 27, no. 1. (January 1995.): 1374-.

Deutsch JH, Hudgins PA, Siegel JL, Peterman SB, b>Devine SM,/b> York R, Wingard JR. "The paranasal sinuses of patients with acute graft-versus-host disease.." AJNR. American Journal of Neuroradiology. Vol. 16, no. 6. (January 1995.): 1287-91.

Gharpure,V,S; Devine,S,M; Holland,H,K; Geller,R,B; OTOOLE,K; Wingard,J,R. "THROMBOTIC THROMBOCYTOPENIC PURPURA ASSOCIATED WITH FK506 FOLLOWING BONE-MARROW TRANSPLANTATION." BONE MARROW TRANSPLANTATION. Vol. 16, no. 5. (November 1995.): 715-716.

Dix,S,P; Devine,S,M; Geller,R,B; Wingard,J,R. "RE - SEVERE INTERACTION BETWEEN METHOTREXATE AND A MACROLIDE-LIKE ANTIBIOTIC." JOURNAL OF THE NATIONAL CANCER INSTITUTE. Vol. 87, no. 21. (November 1995.): 1641-1642.

Dix,S,P; Wingard,J,R; Mullins,R,E; Jerkunica,I; Davidson,T,G; Gilmore,C,E; York,R,C; Lin,L,S; Devine,S,M; Geller,R,B; Heffner,L,T; Hillyer,C,D; Holland,H,K; Winton,E,F; SARAL,R. "Association of busulfan area under the curve with veno-occlusive disease following BMT." BONE MARROW TRANSPLANTATION. Vol. 17, no. 2. (February 1996.): 225-230.

Devine,S,M; Newman,N,J; Siegel,J,L; Joseph,G,J; Geis,T,C; Schneider,J,A; Geller,R,B; Wingard,J,R. "Tacrolimus (FK506)-induced cerebral blindness following bone marrow transplantation." BONE MARROW TRANSPLANTATION. Vol. 18, no. 3. (September 1996.): 569-572.

Holland HK, Dix SP, Geller RB, Devine SM,Heffner LT, Connaghan DG, Hillyer CD, Hughes LL, Miller RL, Moore MR, Winton EF, Wingard JR. "Minimal toxicity and mortality in high-risk breast cancer patients receiving high-dose cyclophosphamide, thiotepa, and carboplatin plus autologous marrow/stem-cell transplantation and comprehensive supportive care.." Journal of Clinical Oncology : Official journal of the American Society of Clinical Oncology. Vol. 14, no. 4. (January 1996.): 1156-64.

Fried MW, Connaghan DG, Sharma S, Martin LG, Devine SM, Holland K, Zuckerman A, Kaufman S, Wingard J, Boyer TD. "Transjugular intrahepatic portosystemic shunt for the management of severe venoocclusive disease following bone marrow transplantation.." Hepatology. Vol. 24, no. 3. (January 1996.): 588-91.

Dix SP, Wingard JR, Mullins RE; Jerkunica I, Davidson TG, Gilmore CE, York RC, Lin LS, b>Devine SM,/b>, Geller RB, Heffner LT, Hillyer CD, Holland HK, Winton EF, Saral R. "Association of busulfan area under the curve with veno-occlusive disease following BMT.." Bone Marrow Transplantation. Vol. 17, no. 2. (January 1996.): 225-30.

b>Devine SM,/b>, Newman NJ, Siegel JL, Joseph GJ, Geis TC, Schneider JA, Geller RB, Wingard JR. "Tacrolimus (FK506)-induced cerebral blindness following bone marrow transplantation.." Bone Marrow Transplantation. Vol. 18, no. 3. (January 1996.): 569-72.

Geller,R,B; Devine,S,M; OTOOLE,K; Persons,L; Keller,J; Mauer,D; Holland,H,K; Dix,S,P; Piotti,M; Redei,I; Connaghan,G; Heffner,L,T; Hillyer,C,D; Waller,E,K; Winton,E,F; Wingard,J,R. "Allogeneic bone marrow transplantation with matched unrelated donors for patients with hematologic malignancies using a preparative regimen of high-dose cyclophosphamide and fractionated total body irradiation." BONE MARROW TRANSPLANTATION. Vol. 20, no. 3. (August 1997.): 219-225.

Wingard,J,R; Nash,R,A; Ratanatharathorn,V; Fay,J,W; Klein,J,L; Przepiorka,D; Maher,R,M; Devine,S,M; Boswell,G; Bekersky,I; Fitzsimmons,W. "Lack of interaction between tacrolimus (FK506) and methotrexate in bone marrow transplant recipients." BONE MARROW TRANSPLANTATION. Vol. 20, no. 1. (July 1997.): 49-51.

Geller RB, b>Devine SM,/b>, O'Toole K, Persons L, Keller J, Mauer D, Holland HK, Dix SP, Piotti M, Redei I, Connaghan G, Heffner LT, Hillyer CD, Waller EK, Winton EF, Wingard JR. "Allogeneic bone marrow transplantation with matched unrelated donors for patients with hematologic malignancies using a preparative regimen of high-dose cyclophosphamide and fractionated total body irradiation.." Bone Marrow Transplantation. Vol. 20, no. 3. (January 1997.): 219-25.

b>Devine SM,/b>, Geller RB, Lin LB, Dix SP, Holland HK, Maurer D, O'Toole K, Keller J, Connaghan DG; Heffner LT, Hillyer CD, Rodey GE, Winton EF, Maher RM, Fitzsimmons WE, Wingard JR. "The outcome of unrelated donor bone marrow transplantation in patients with hematologic malignancies using tacrolimus (FK506) and low dose methotrexate for graft-versus-host disease prophylaxis.." Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation. Vol. 3, no. 1. (January 1997.): 25-33.

Wingard JR, Nash RA, Ratanatharathorn V, Fay JW, Klein JL, Przepiorka D, Maher RM Devine SM, Boswell G, Bekersky I, Fitzsimmons W. "Lack of interaction between tacrolimus (FK506) and methotrexate in bone marrow transplant recipients.." Bone Marrow Transplantation. Vol. 20, no. 1. (January 1997.): 49-51.

Redei,I; Waller,E,K; Holland,H,K; Devine,S,M; Wingard,J,R. "Successful engraftment after primary graft failure in aplastic anemia using G-CSF mobilized peripheral stem cell transfusions." BONE MARROW TRANSPLANTATION. Vol. 19, no. 2. (January 1997.): 175-177.

Redei I, Waller EK, Holland HK, Devine SM, Wingard JR. "Successful engraftment after primary graft failure in aplastic anemia using G-CSF mobilized peripheral stem cell transfusions.." Bone Marrow Transplantation. Vol. 19, no. 2. (January 1997.): 175-7.

Devine,S,M; Geller,R,B; Lin,L,B; Dix,S,P; Holland,H,K; Maurer,D; O'Toole,K; Keller,J; Connaghan,D,G; Heffner,L,T; Hillyer,C,D; Rodey,G,E; Winton,E,F; Maher,R,M; Fitzsimmons,W,E; Wingard,J,R. "The outcome of unrelated donor bone marrow transplantation in patients with hematologic malignancies using tacrolimus (FK506) and low dose methotrexate for graft-versus-host disease prophylaxis.." Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. Vol. 3, no. 1. (April 1997.): 25-33.

Ratanatharathorn,V; Nash,R,A; Przepiorka,D; Devine,S,M; Klein,J,L; Weisdorf,D; Fay,J,W; Nademanee,A; Antin,J,H; Christiansen,N,P; van der Jagt,R; Herzig,R,H; Litzow,M,R; Wolff,S,N; Longo,W,L; Petersen,F,B; Karanes,C; Avalos,B; STORB,R; Buell,D,N; Maher,R,M; Fitzsimmons,W,E; Wingard,J,R. "Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation." BLOOD. Vol. 92, no. 7. (October 1998.): 2303-2314.

Ratanatharathorn, V; Nash, R, A; Przepiorka, D; Devine, S, M; Klein, J, L; Weisdorf, D; Fay, J, W; Nademanee, A; Antin, J, H; Christiansen, N, P; van der Jagt, R; Herzig, R, H; Litzow, M, R; Wolff, S, N; Longo, W, L; Petersen, F, B; Karanes, C; Avalos, B; Storb, R; Buell, D, N; et al.. "Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation.." Blood. Vol. 92, no. 7. (January 1998.): 2303-14.

Przepiorka D, Devine S, Fay J, Uberti J, Wingard J. "Practical considerations in the use of tacrolimus for allogeneic marrow transplantation.." Bone Marrow Transplantation. Vol. 24, no. 10. (January 1999.): 1053-6.

Przepiorka,D; Devine,S,M; Fay,J,W; Uberti,J,P; Wingard,J,R. "Practical considerations in the use of tacrolimus for allogeneic marrow transplantation." BONE MARROW TRANSPLANTATION. Vol. 24, no. 10. (November 1999.): 1053-1056.

Devine, S, M; Hoffman, R. "Role of mesenchymal stem cells in hematopoietic stem cell transplantation.." Current Opinion in Hematology. Vol. 7, no. 6. (January 2000.): 358-63.

Lonial,S; Jones,T,W; Devine,S; Winton,E,F; Heffner,L,T; Smith,K,J; Yeager,A,M; Waller,E,K. "High dose chemotherapy without hematopoietic cell support for the treatment of refractory lymphoma." LEUKEMIA & LYMPHOMA. Vol. 36, no. 5-6. (February 2000.): 497-502.

van Besien, K; Bartholomew, A; Stock, W; Peace, D; Devine, S; Sher, D; Sosman, J; Chen, Y, H; Koshy, M; Hoffman, R. "Fludarabine-based conditioning for allogeneic transplantation in adults with sickle cell disease.." Bone Marrow Transplantation. Vol. 26, no. 4. (January 2000.): 445-9.

Van Besien,K; Bartholomew,A; Stock,W; Peace,D; Devine,S; Sher,D; Sosman,J; Chen,Y,H; Koshy,M; Hoffman,R. "Fludarabine-based conditioning for allogeneic transplantation in adults with sickle cell disease." BONE MARROW TRANSPLANTATION. Vol. 26, no. 4. (August 2000.): 445-449.

Devine,S,M; Hoffman,R. "Role of mesenchymal stem cells in hematopoietic stem cell transplantation." CURRENT OPINION IN HEMATOLOGY. Vol. 7, no. 6. (November 2000.): 358-363.

Lonial S, Jones TW, Devine S, Winton EF, Heffner LT, Smith KJ, Yeager AM, Waller EK. "High dose chemotherapy without hematopoietic cell support for the treatment of refractory lymphoma.." Leukemia & Lymphoma. Vol. 36, no. 5-6. (January 2000.): 497-502.

Van Besien,K; Koshy,M; Anderson-Shaw,L; Talishy,N; Dorn,L; Devine,S; Yassine,M; Kodish,E. "Allogeneic stem cell transplantation for sickle cell disease. A study of patients' decisions." BONE MARROW TRANSPLANTATION. Vol. 28, no. 6. (September 2001.): 545-549.

Devine,S,M; Sanborn,R; Jessop,E; Stock,W; Huml,M; Peace,D; Wickrema,A; Yassine,M; Amin,K; Thomason,D; Chen,Y,H; Devine,H; Maningo,M; Van Besien,K. "Fludarabine and melphalan-based conditioning for patients with advanced hematological malignancies relapsing after a previous hematopoietic stem cell transplant." BONE MARROW TRANSPLANTATION. Vol. 28, no. 6. (September 2001.): 557-562.

Bartholomew,A; Sher,D; Sosler,S; Stock,W; Lazda,V; Koshy,M; Devine,S; Vanbesien,K. "Stem cell transplantation eliminates alloantibody in a highly sensitized patient." TRANSPLANTATION. Vol. 72, no. 10. (November 2001.): 1653-1655.

Devine, S, M; Sanborn, R; Jessop, E; Stock, W; Huml, M; Peace, D; Wickrema, A; Yassine, M; Amin, K; Thomason, D; Chen, Y, H; Devine, H; Maningo, M; van Besien, K. "Fludarabine and melphalan-based conditioning for patients with advanced hematological malignancies relapsing after a previous hematopoietic stem cell transplant.." Bone Marrow Transplantation. Vol. 28, no. 6. (January 2001.): 557-62.

Devine, S, M; Peter, S; Martin, B, J; Barry, F; McIntosh, K R. "Mesenchymal stem cells: stealth and suppression.." Cancer Journal (Sudbury, Mass.). Vol. 7 Suppl 2, (January 2001.): S76-82.

Bartholomew, A; Sher, D; Sosler, S; Stock, W; Lazda, V; Koshy, M; Devine, S; vanBesien, K. "Stem cell transplantation eliminates alloantibody in a highly sensitized patient.." Transplantation. Vol. 72, no. 10. (January 2001.): 1653-5.

Bartholomew, A; Patil, S; Mackay, A; Nelson, M; Buyaner, D; Hardy, W; Mosca, J; Sturgeon, C; Siatskas, M; Mahmud, N; Ferrer, K; Deans, R; Moseley, A; Hoffman, R; Devine, S M. "Baboon mesenchymal stem cells can be genetically modified to secrete human erythropoietin in vivo.." Human Gene Therapy. Vol. 12, no. 12. (January 2001.): 1527-41.

Mahmud,N; Devine,S,M; Weller,K,P; Parmar,S; Sturgeon,C; Nelson,M,C; Hewett,T; Hoffman,R. "The relative quiescence of hematopoietic stem cells in nonhuman primates." BLOOD. Vol. 97, no. 10. (May 2001.): 3061-3068.

Mahmud, N; Devine, S, M; Weller, K, P; Parmar, S; Sturgeon, C; Nelson, M, C; Hewett, T; Hoffman, R. "The relative quiescence of hematopoietic stem cells in nonhuman primates.." Blood. Vol. 97, no. 10. (January 2001.): 3061-8.

van Besien, K; Koshy, M; Anderson-Shaw, L; Talishy, N; Dorn, L; Devine, S; Yassine, M; Kodish, E. "Allogeneic stem cell transplantation for sickle cell disease. A study of patients' decisions.." Bone Marrow Transplantation. Vol. 28, no. 6. (January 2001.): 545-9.

Sosman, J, A; Stiff, P; Moss, S, M; Sorokin, P; Martone, B; Bayer, R; van Besien, K; Devine, S; Stock, W; Peace, D; Chen, Y; Long, C; Gustin, D; Viana, M; Hoffman, R. "Pilot trial of interleukin-2 with granulocyte colony-stimulating factor for the mobilization of progenitor cells in advanced breast cancer patients undergoing high-dose chemotherapy: expansion of immune effectors within the stem-cell graft and." Journal of Clinical Oncology : official journal of the American Society of Clinical Oncology. Vol. 19, no. 3. (January 2001.): 634-44.

Devine SM, Jahagirdar B, van Besien K. "Reduced duration of cytopenias following melphalan conditioning and autografting for multiple myeloma." Blood 99. (January 2002.): 4251-4252.

Devine,S,M; Jahagirdar,B; Van Besien,K. "Reduced duration of cytopenias following melphalan conditioning and autografting for multiple myeloma." BLOOD. Vol. 99, no. 11. (June 2002.): 4251-4252.

Devine,S,M; Hoffman,R; Verma,A; Shah,R; Bradlow,B,A; Stock,W; Maynard,V; Jessop,E; Peace,D; Huml,M; Thomason,D; Chen,Y,H; Van Besien,K. "Allogeneic blood cell transplantation following reduced-intensity conditioning is effective therapy for older patients with myelofibrosis with myeloid metaplasia." BLOOD. Vol. 99, no. 6. (March 2002.): 2255-2258.

Devine SM, Hoffman R, Verma A, Shah R, Bradlow BA, Stock W, Maynard V, Jessop E, Peace D, Huml M, Thomason E, Chen YH, van Besien K. "Allogeneic blood cell transplantation following reduced-intensity conditioning is effective therapy for older patients with myelofibrosis with myeloid metaplasia." Blood. no. 99. (January 2002.): 2255-2258.

Bartholomew, Amelia; Sturgeon, Cord; Siatskas, Mandy; Ferrer, Karen; McIntosh, Kevin; Patil, Sheila; Hardy, Wayne; Devine, Steve; Ucker, David; Deans, Robert; Moseley, Annemarie; Hoffman, Ronald. "Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo.." Experimental hematology. Vol. 30, no. 1. (January 2002.): 42-8.

Bartholomew,A; Sturgeon,C; Siatskas,M; Ferrer,K; MCINTOSH,K; Patil,S; Hardy,W; Devine,S; Ucker,D; Deans,R; Moseley,A; Hoffman,R. "Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo." EXPERIMENTAL HEMATOLOGY. Vol. 30, no. 1. (January 2002.): 42-48.

Chohan,R; Vij,R; Adkins,D; Blum,W; Brown,R; Tomasson,M; Devine,S; Graubert,T; GOODNOUGH,L,T; DiPersio,J,F; Khoury,H. "Long-term outcomes of allogeneic stem cell transplant recipients after calcineurin inhibitor-induced neurotoxicity." BRITISH JOURNAL OF HAEMATOLOGY. Vol. 123, no. 1. (October 2003.): 110-113.

Verma, A; Devine, S; Morrow, M; Chen, Y-H; Mihalov, M; Peace, D; Stock, W; Pursell, K; Wickrema, A; Yassine, M; Jessop, E; van Besien, K. "Low incidence of CMV viremia and disease after allogeneic peripheral blood stem cell transplantation. Role of pretransplant ganciclovir and post-transplant acyclovir.." Bone Marrow Transplantation. Vol. 31, no. 9. (January 2003.): 813-6.

Van Besien, K; Devine, S; Wickrema, A; Jessop, E; Amin, K; Yassine, M; Maynard, V; Stock, W; Peace, D; Ravandi, F; Chen, Y-H; Hoffman, R; Sossman, J. "Regimen-related toxicity after fludarabine-melphalan conditioning: a prospective study of 31 patients with hematologic malignancies.." Bone Marrow Transplantation. Vol. 32, no. 5. (January 2003.): 471-6.

Van Besien K; Devine S; Wickrema A; Jessop E; Amin K; Yassine M; Maynard V; Stock W; Peace D; Ravandi F; Chen, Y-H; Cheung, T; Vijayakumar S; Hoffman R; Sosman J. "Safety and outcome after fludarabine-thiotepa-TBI conditioning for allogeneic transplantation: a prospective study of 30 patients with hematologic malignancies.." Bone Marrow Transplant. Vol. 32, (January 2003.): 9-13.

Cottler-Fox, Michele, H; Lapidot, Tsvee; Petit, Isabelle; Kollet, Orit; DiPersio, John, F; Link, Dan; Devine, Steven. "Stem cell mobilization.." Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program. (January 2003.): 419-37.

Van Besien,K; Devine,S; Wickrema,A; Jessop,E; Amin,K; Yassine,M; Maynard,V; Stock,W; Peace,D; Ravandi,F; Chen,Y,D; Hoffman,R; Sossman,J. "Regimen-related toxicity after fludarabine-melphalan conditioning: a prospective study of 31 patients with hematologic malignancies." BONE MARROW TRANSPLANTATION. Vol. 32, no. 5. (September 2003.): 471-476.

Blum,W; Khoury,H; Lin,H,S; Vij,R; GOODNOUGH,L,T; Devine,S; DiPersio,J; Adkins,D. "Primary amyloidosis patients with significant organ dysfunction tolerate autologous transplantation after conditioning with single-dose total body irradiation alone: A feasibility study." BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. Vol. 9, no. 6. (June 2003.): 397-404.

Devine,S,M; Adkins,D,R; Khoury,H; Brown,R,A; Vij,R; Blum,W; DiPersio,J,F. "Recent advances in allogeneic hematopoietic stem-cell transplantation." JOURNAL OF LABORATORY AND CLINICAL MEDICINE. Vol. 141, no. 1. (January 2003.): 7-32.

Devine,S,M; Lazarus,H,M; Emerson,S. "Clinical application of hematopoietic progenitor cell expansion: current status and future prospects." BONE MARROW TRANSPLANTATION. Vol. 31, no. 4. (February 2003.): 241-252.

Vij, R; Khoury, H; Brown, R; Goodnough, L, T; Devine, S, M; Blum, W; Adkins, D; DiPersio, J F. "Low-dose short-course intravenous ganciclovir as pre-emptive therapy for CMV viremia post allo-PBSC transplantation.." Bone Marrow Transplantation. Vol. 32, no. 7. (January 2003.): 703-7.

Vij,R; DiPersio,J,F; Venkatraman,P; Trinkaus,K; GOODNOUGH,L,T; Brown,R,A; Khoury,H,J; Devine,S,M; Oza,A; Shenoy,S; Blum,W; Adkins,D. "Donor CMV serostatus has no impact on CMV viremia or disease when prophylactic granulocyte transfusions are given following allogeneic peripheral blood stem cell transplantation." BLOOD. Vol. 101, no. 5. (March 2003.): 2067-2069.

Vij R, DiPersio JF, Venkatraman P, Trinkaus K, Goodnough LT, Brown RA, Khoury HJ, Devine SM, Oza A, Shenoy S, Blum W, Adkins D. "Donor CMV serostatus has no impact on CMV viremia or disease when prophylactic granulocyte transfusions are given following allogeneic peripheral blood stem cell transplantation." Blood. no. 101. (January 2003.): 2067-2069.

Verma,A; Devine,S; Morrow,M; Chen,Y,H; Mihalov,M; Peace,D; Stock,W; Pursell,K; Wickrema,A; Yassine,M; Jessop,E; van Besin,K. "Low incidence of CMV viremia and disease after allogeneic peripheral blood stem cell transplantation. Role of pretransplant ganciclovir and post-transplant acyclovir." BONE MARROW TRANSPLANTATION. Vol. 31, no. 9. (May 2003.): 813-816.

Devine, S, M; Lazarus, H, M; Emerson, S G. "Clinical application of hematopoietic progenitor cell expansion: current status and future prospects.." Bone marrow transplantation. Vol. 31, no. 4. (January 2003.): 241-52.

Devine SM, Cobbs C, Jennings M, Bartholomew A, Hoffman R. "Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into non-human primates." Blood. no. 101. (January 2003.): 2999-3001.

Devine SM, Adkins DR, Khoury H, Brown RA, Vij R, Blum W, Dipersio JF. "Recent advances in allogeneic hematopoietic stem-cell transplantation." J Lab Clin Med. no. 141. (January 2003.): 7-32.

Chohan, Rizwana; Vij, Ravi; Adkins, Douglas; Blum, William; Brown, Randy; Tomasson, Michael; Devine, Steven; Graubert, Timothy; Goodnough, Lawrence, T; DiPersio, John, F; Khoury, Hanna. "Long-term outcomes of allogeneic stem cell transplant recipients after calcineurin inhibitor-induced neurotoxicity.." British journal of haematology. Vol. 123, no. 1. (January 2003.): 110-3.

Blum, William; Khoury, Hanna; Lin, H-S; Vij, Ravi; Goodnough, Lawrence, T; Devine, Steve; Dipersio, John; Adkins, Douglas. "Primary amyloidosis patients with significant organ dysfunction tolerate autologous transplantation after conditioning with single-dose total body irradiation alone: a feasibility study.." Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. Vol. 9, no. 6. (January 2003.): 397-404.

Van Besien,K; Devine,S; Wickrema,A; Jessop,E; Amin,K; Yassine,M; Maynard,V; Stock,W; Peace,D; Ravandi,F; Chen,Y,H; Cheung,T; Vijayakumar,S; Hoffman,R; Sosman,J. "Safety and outcome after fludarabine-thiotepa-TBI conditioning for allogeneic transplantation: a prospective study of 30 patients with hematologic malignancies." BONE MARROW TRANSPLANTATION. Vol. 32, no. 1. (July 2003.): 9-13.

Vij,R; Khoury,H; Brown,R; GOODNOUGH,L,T; Devine,S,M; Blum,W; Adkins,D; DiPersio,J,F. "Low-dose short-course intravenous ganciclovir as pre-emptive therapy for CMV viremia post allo-PBSC transplantation." BONE MARROW TRANSPLANTATION. Vol. 32, no. 7. (October 2003.): 703-707.

Devine,S,M; Cobbs,C; Jennings,M; Bartholomew,A; Hoffman,R. "Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates." BLOOD. Vol. 101, no. 8. (April 2003.): 2999-3001.

Khoury,J,A; Dubberke,E,R; Devine,S,M. "Fatal case of protothecosis in a hematopoietic stem cell transplant recipient after infliximab treatment for graft-versus-host disease." BLOOD. Vol. 104, no. 10. (November 2004.): 3414-3415.

Hofling, A Alex; Sands, Mark, S; Lublin, Douglas, M; Bauer, Gerhard; Devine, Steven. "Collection of a mobilized peripheral blood apheresis product from a patient with mucopolysaccharidosis type VII and subsequent CD34+ cell isolation.." Journal of clinical apheresis. Vol. 19, no. 3. (January 2004.): 151-3.

Hofling,A,A; Sands,M,S; Lublin,D,M; Bauer,G; Devine,S. "Collection of a mobilized peripheral blood apheresis product from a patient with mucopolysaccharidosis type VII and subsequent CD34+cell isolation." JOURNAL OF CLINICAL APHERESIS. Vol. 19, no. 3. (January 2004.): 151-153.

Hidalgo JD, Krone R, Rich MW, Blum K, Adkins D, Fan MY, Brown R, b>Devine SM,/b>, Graubert T, Blum W, Tomasson M, Goodnough LT, Vij R, DiPersio J, Khoury H. "Supraventricular tachyarrhythmias after hematopoietic stem cell transplantation: incidence, risk factors and outcomes.." Bone marrow transplantation. Vol. 34, no. 7. (January 2004.): 615-9.

Khoury JA, Dubberke ER, Devine SM. "Fatal case of protothecosis in a hematopoietic stem cell transplant recipient after infliximab treatment for graft-versus-host disease." Blood. no. 104. (January 2004.): 3414-3415.

Hofling,A,A; Devine,S; Vogler,C; Sands,M,S. "Human CD34(+) hematopoietic progenitor cell-directed lentiviral-mediated gene therapy in a xenotransplantation model of lysosomal storage disease." MOLECULAR THERAPY. Vol. 9, no. 6. (June 2004.): 856-865.

Hidalgo,J,D; Krone,R; Rich,M,W; Blum,K; Adkins,D; Fan,M,Y; Brown,R; Devine,S; Graubert,T; Blum,W; Tomasson,M; GOODNOUGH,L,T; Vij,R; DiPersio,J; Khoury,H. "Supraventricular tachyarrhythmias after hematopoietic stem cell transplantation: incidence, risk factors and outcomes." BONE MARROW TRANSPLANTATION. Vol. 34, no. 7. (October 2004.): 615-619.

Mahmud,N; Pang,W,X; Cobbs,C; Alur,P; Borneman,J; Dodds,R; Archambault,M; Devine,S; Turian,J; Bartholomew,A; Vanguri,P; MacKay,A; Young,R; Hoffman,R. "Studies of the route of administration and role of conditioning with radiation on unrelated allogeneic mismatched mesenchymal stem cell engraftment in a nonhuman primate model." EXPERIMENTAL HEMATOLOGY. Vol. 32, no. 5. (May 2004.): 494-501.

Hallemeier,C; Girgis,M; Blum,W; Brown,R; Khoury,H; GOODNOUGH,L,T; Vij,R; Devine,S; Wehde,M; Postma,S; Lin,H,S; Dipersio,F; Adkins,D. "Outcomes of adults with acute myelogenous leukemia in remission given 550 cGy of single-exposure and total body irradiation, cyclophosphamide, unrelated donor bone marrow transplants." BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. Vol. 10, no. 5. (May 2004.): 310-319.

Cashen,Amanda,F; Link,Daniel; Devine,Steven; DiPersio,John. "Cytokines and stem cell mobilization for autologous and allogeneic transplantation.." Current hematology reports. Vol. 3, no. 6. (November 2004.): 406-412.

Van Besien, Koen; Mehra, Rakesh; Wadehra, Navin; Stock, Wendy; Khouri, Issa; Giralt, Sergio; Devine, Steve; Wickrema, Amittha; Peace, David; Sosman, Jeff; Gajewski, Jim; Champlin, Richard. "Phase II study of autologous transplantation with interleukin-2-incubated peripheral blood stem cells and posttransplantation interleukin-2 in relapsed or refractory non-Hodgkin lymphoma.." Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. Vol. 10, no. 6. (January 2004.): 386-94.

Hofling, A Alex; Devine, Steven; Vogler, Carole; Sands, Mark S. "Human CD34+ hematopoietic progenitor cell-directed lentiviral-mediated gene therapy in a xenotransplantation model of lysosomal storage disease.." Molecular therapy : the journal of the American Society of Gene Therapy. Vol. 9, no. 6. (January 2004.): 856-65.

Hoerr, Amy, L; Gao, Feng; Hidalgo, Josephine; Tiwari, Divya; Blum, Kristie, A; Mathews, Vikram; Adkins, Douglas, R; Blum, William; Devine, Steven; Vij, Ravi; Goodnough, Lawrence, T; Dipersio, John, F; Khoury, Hanna J. "Effects of pretransplantation treatment with rituximab on outcomes of autologous stem-cell transplantation for non-Hodgkin's lymphoma.." Journal of clinical oncology : official journal of the American Society of Clinical Oncology. Vol. 22, no. 22. (January 2004.): 4561-6.

Hallemeier C, Girgis M, Blum W, Brown R, Khoury H, Goodnough L, T, Vij R, b>Devine SM,/b>, Wehde M, Postma S, Lin HS, DiPersio J, Adkins D. "Outcomes of adults with acute myelogenous leukemia in remission given 550 cGy of single-exposure total body irradiation, cyclophosphamide, and unrelated donor bone marrow transplants.." Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation. Vol. 10, no. 5. (January 2004.): 310-9.

Cashen, Amanda, F; Link, Daniel; Devine, Steven; DiPersio, John. "Cytokines and stem cell mobilization for autologous and allogeneic transplantation.." Current Hematology Reports. Vol. 3, no. 6. (January 2004.): 406-12.

van Besien,K; Mehra,R; Wadehra,N; Stock,W; Khouri,I; Giralt,S; Devine,S; Wickrema,A; Peace,D; Sosman,J; Gajewski,J; Champlin,R. "Phase II study of autologous transplantation with interleukin-2-incubated peripheral blood stem cells and posttransplantation interleukin-2 in relapsed or refractory non-Hodgkin lymphoma." BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. Vol. 10, no. 6. (June 2004.): 386-394.

Mahmud, Nadim; Pang, Wenxin; Cobbs, Carrington; Alur, Prasad; Borneman, Jade; Dodds, Robert; Archambault, Michael; Devine, Steven; Turian, Julius; Bartholomew, Amelia; Vanguri, Padmavathy; Mackay, Alastair; Young, Randell; Hoffman, Ronald. "Studies of the route of administration and role of conditioning with radiation on unrelated allogeneic mismatched mesenchymal stem cell engraftment in a nonhuman primate model.." Experimental Hematology. Vol. 32, no. 5. (January 2004.): 494-501.

Devine SM, Flomenbert N, Vesole DH, Liesveld J, Weisdorf D, Badel K, Calandra G, DiPersio JF. "Rapid mobilization of CD34+cells following administration of the CXCR4 antagonist AMD3100 to patients with multiple myeloma and non-Hodgkin's lymphoma." J Clin Oncol. no. 22. (January 2004.): 1095-1102.

Hiemenz,J; Cagnoni,P; Simpson,D; Devine,S; Chao,N; Keirns,J; Lau,W; Facklam,D; Buell,D. "Pharmacokinetic and maximum tolerated dose study of micafungin in combination with fluconazole versus fluconazole alone for prophylaxis of fungal infections in adult patients undergoing a bone marrow or peripheral stem cell transplant." ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. Vol. 49, no. 4. (April 2005.): 1331-1336.

Hiemenz, J; Cagnoni, P; Simpson, D; Devine, S; Chao, N; Keirns, J; Lau, W; Facklam, D; Buell, D. "Pharmacokinetic and maximum tolerated dose study of micafungin in combination with fluconazole versus fluconazole alone for prophylaxis of fungal infections in adult patients undergoing a bone marrow or peripheral stem cell transplant.." Antimicrobial Agents and Chemotherapy. Vol. 49, no. 4. (January 2005.): 1331-6.

Friedman, J; Khoury, H; Adkins, D; Devine, S; Nervi, B; Edwards, T; Dipersio, J; Vij, R. "Pilot study of 13cis-retinoic acid+dexamethasone+alpha interferon as maintenance therapy following high-dose chemotherapy and autologous stem cell transplant for multiple myeloma.." Bone Marrow Transplantation. Vol. 35, no. 10. (January 2005.): 979-84.

Devine, S, M; Brown, R, A; Mathews, V; Trinkaus, K; Khoury, H; Adkins, D; Vij, R; Sempek, D; Graubert, T; Tomasson, M; Goodnough, L, T; DiPersio, J F. "Reduced risk of acute GVHD following mobilization of HLA-identical sibling donors with GM-CSF alone.." Bone Marrow Transplantation. Vol. 36, no. 6. (January 2005.): 531-8.

Devine,S,M; Brown,R,A; Mathews,V; Trinkaus,K; Khoury,H; Adkins,D; Vij,R; Sempek,D; Graubert,T; Tomasson,M; GOODNOUGH,L,T; DiPersio,J,F. "Reduced risk of acute GVHD following mobilization of HLA-identical sibling donors with GM-CSF alone." BONE MARROW TRANSPLANTATION. Vol. 36, no. 6. (September 2005.): 531-538.

Girgis,M; Hallemeier,C; Blum,W; Brown,R; Lin,H,S; Khoury,H; GOODNOUGH,L,T; Vij,R; Devine,S; Wehde,M; Postma,S; Oza,A; DiPersio,J; Adkins,D. "Chimerism and clinical outcomes of 110 recipients of unrelated donor bone marrow transplants who underwent conditioning with low-dose, single-exposure total body irradiation and cyclophosphamide." BLOOD. Vol. 105, no. 8. (April 2005.): 3035-3041.

Flomenberg N, Devine SM, DiPersio JF, Liesveld JL, McCarty JM, Rowley SD, Vesole DH, Badel K, Calandra G. "The use of AMD3100 plus G-CSF for autologous hematopoietic progenitor cell mobilization is superior to G-CSF alone." Blood. Vol. n/a, no. 106. (January 2005.): 1867-1874.

Friedman,J; Khoury,H; Adkins,D; Devine,S; Nervi,B; Edwards,T; DiPersio,J; Vij,R. "Pilot study of 13cis-retinoic acid plus dexamethasone plus alpha interferon as maintenance therapy following high-dose chemotherapy and autologous stem cell transplant for multiple myeloma." BONE MARROW TRANSPLANTATION. Vol. 35, no. 10. (May 2005.): 979-984.

Lazarus HM, Koc ON, Devine SM, Curtin P, Maziarz RT, Holland HK, Shpall EJ, McCarthy P, Atkinson K, Cooper BW, Gerson SL, Laughlin MJ, Loberiza FR, Moseley AB, Bacigalupo A. "Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients." Biol Blood Marrow Transplant. no. 11. (January 2005.): 389-398.

Girgis, Mark; Hallemeier, Chris; Blum, William; Brown, Randy; Lin, Hsiu-San; Khoury, Hanna; Goodnough, L Tim; Vij, Ravi; Devine, Steve; Wehde, Marita; Postma, Stacey; Oza, Aarti; Dipersio, John; Adkins, Douglas. "Chimerism and clinical outcomes of 110 recipients of unrelated donor bone marrow transplants who underwent conditioning with low-dose, single-exposure total body irradiation and cyclophosphamide.." Blood. Vol. 105, no. 8. (January 2005.): 3035-41.

Brenner, W; Storch, G; Buller, R; Vij, R; Devine, S; DiPersio, J. "West Nile Virus encephalopathy in an allogeneic stem cell transplant recipient: use of quantitative PCR for diagnosis and assessment of viral clearance.." Bone Marrow Transplantation. Vol. 36, no. 4. (January 2005.): 369-70.

Lazarus,H,M; Koc,O,N; Devine,S,M; Curtin,P; Maziarz,R,T; Holland,H,K; Shpall,E,J; McCarthy,P; Atkinson,K; Cooper,B,W; Gerson,S,L; Laughlin,M,J; Loberiza,F,R; Moseley,A,B; Bacigalupo,A. "Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients." BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. Vol. 11, no. 5. (May 2005.): 389-398.

Shepherd,Rebecca,M; Capoccia,Benjamin,J; Devine,Steven,M; DiPersio,John; Trinkaus,Kathryn,M; Ingram,David; Link,Daniel,C. "Angiogenic cells can be rapidly mobilized and efficiently harvested from the blood following treatment with AMD3100." BLOOD. Vol. 108, no. 12. (December 2006.): 3662-3667.

Verkruyse, L, A; Storch, G, A; Devine, S, M; Dipersio, J, F; Vij, R. "Once daily ganciclovir as initial pre-emptive therapy delayed until threshold CMV load > or =10000 copies/ml: a safe and effective strategy for allogeneic stem cell transplant patients.." Bone marrow transplantation. Vol. 37, no. 1. (January 2006.): 51-6.

Shepherd RM, Capoccia BJ, Devine SM, DiPersio J, Trinkaus KM, Ingram D, Link DC. "Angiogenic cells can be rapidly mobilized and efficiently harvested from the blood following treatment with AMD3100." Blood. Vol. 108, no. December. (January 2006.): 3662-3667.

Hallemeier CL, Girgis MD, Blum WG, Brown RA, Khoury HJ, Devine SM, Vij R, Lin HS, DiPersio JF, Adkins DA. "Long term remissions in patients with myelodysplastic syndrome and secondary acute myelogeneous leukemia undergoing allogeneic transplantation following a reduced intensity conditioning regimen of 550cGy total body irradiation and cyclophosphamide." Biol Blood Marrow Transplant. Vol. 7, no. 12. (January 2006.): 749-757.

Bennett,Charles,L; Evens,Andrew,M; Andritsos,Leslie,A; Balasubramanian,Lakshmi; Mai,Mark; Fisher,Matthew,J; Kuzel,Timothy,M; Angelotta,Cara; McKoy,June,M; Vose,Julie,M; Bierman,Philip,J; Kuter,David,J; Trifilio,Steven,M; Devine,Steven,M; Tallman,Martin,S. "Haematological malignancies developing in previously healthy individuals who received haematopoietic growth factors: report from the Research on Adverse Drug Events and Reports (RADAR) project." BRITISH JOURNAL OF HAEMATOLOGY. Vol. 135, no. 5. (December 2006.): 642-650.

Bennett CL, Evens AM, Andritsos LA, Balasubramanian L, Mai M, Fisher MJ, Kuzel TM, Angelotta C, McKoy JM, Vose JM, Bierman PJ, Kuter DJ, Trifilio SM, Devine SM, Tallman MS. "Haematological malignancies developing in previously healthy individuals who received haematopoietic growth factors: report from the Research on Adverse Drug Events and Reports (RADAR) project." British Journal of Haematology. no. December. (January 2006.): 642-650.

Hallemeier,Christopber,L; Girgis,Mark,D; Blum,William,G; Brown,Randy,A; Khoury,Hanna,J; Devine,Steven,M; Vij,Ravi; Lin,Hsu-san; DiPersio,John,F; Adkins,Douglas,R. "Long-term remissions in patients with myelodysplastic syndrome and secondary acute myelogenous leukemia undergoing allogeneic transplantation following a reduced intensity conditioning regimen of 550 cGy total body irradiation and cyclophosphamide." BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. Vol. 12, no. 7. (July 2006.): 749-757.

Oza, Aarti; Hallemeier, Chris; Goodnough, Lawrence; Khoury, Hanna; Shenoy, Shalini; Devine, Steven; Augustin, Kristan; Vij, Ravi; Trinkaus, Kathryn; Dipersio, John, F; Adkins, Douglas. "Granulocyte-colony-stimulating factor-mobilized prophylactic granulocyte transfusions given after allogeneic peripheral blood progenitor cell transplantation result in a modest reduction of febrile days and intravenous antibiotic usage.." Transfusion. Vol. 46, no. 1. (January 2006.): 14-23.

Awan,Farrukh; Hamadani,Mehdi; Devine,Steven. "Paraneoplastic Sweet's syndrome and the pathergy phenomenon." ANNALS OF HEMATOLOGY. Vol. 86, no. 8. (August 2007.): 613-614.

Dubberke Er, Sadhu J, Gatti R, Reske KA, DiPersion JF, Devine SM, Fraser VJ. "Severity of Clostridium difficile-associated disease (CDAD) in allogeneic stem cell transplant recipients: evaulation of a CDAD severity grading system.." Infect Control Hosp Epidemiol. Vol. 28, no. 2. (February 2007.): 208-211.

Gregg A, Bottle SE, Devine SM, Figler H, Linden J, White P, Pouton CW, Urmaliya V. Scammells PJ. "Dual acting antioxidant A1 adenosine receptor agonists." Bioorg Med Chem Lett. Vol. 17, no. 19. (October 2007.): 5437-5441.

Fong T, Trinkaus K, Adkins DVij R, Devine SM, Tomasson M, Goodnough LT, Lopez S, Graubert T, Shenoy S, Dipersio JF, Khoury HJ. "A randomized double-blind trial of hydroxychloroquine for the prevention of chronic graft-versus-host disease after allogeneic peripheral blood stem cell transplantation." Biol Blood Marrow Transplant. Vol. 13, no. 10. (October 2007.): 1201-1206.

Hamadani M, Benson DM, Blum W, Garzon R, Devine SM. "Pulmonary Nocardia and Aspergillus co-infection in a patient with chronic graft-versus-host disease." Transpl Infect Dis. Vol. 1, no. 10. (January 2007.): 24-26.

Cashen, A, F; Lazarus, H, M; Devine, S M. "Mobilizing stem cells from normal donors: is it possible to improve upon G-CSF?." Bone marrow transplantation. Vol. 39, no. 10. (January 2007.): 577-88.

Hamadani M, Benson DM, Blum W, Garzon R, Devine SM,. "Pulmonary and Aspergillus co-infection in a patient with chronic graft-versus-host disease.." Transpl Infect Dis. Vol. 25, (July 2007.): -.

Mehdi Hamadani, Farrukh Awan, Patrick Elder, Pierluigi Porcu, Thomas Lin, Kristie Blum, Diane Scholl, and Steven M. Devine. "Allogeneic Hematopoietic Stem Cell Transplantation for Peripheral T-Cell Lymphoma: Evidence of Graft-Versus-Lymphoma Effect." Blood (ASH Annual Meeting Abstracts. Vol. 110, (November 2007.): 3044-.

Fong,Thomas; Trinkaus,Aathryn; Adkins,Douglas; Vij,Ravi; Devine,Steven,M; Tomasson,Michael; Goodnough,Lawrence,T; Lopez,Sandra; Graubert,Timothy; Shenoy,Shalini; DiPersio,John,F; Khoury,Hanna,Y. "A randomized double-blind trial of hydroxychloroquine for the prevention of chronic graft-versus-host disease after allogeneic peripheral blood stem cell transplantation." BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. Vol. 13, no. 10. (October 2007.): 1201-1206.

Blum W, Klisovic RB, Hackanson B, Liu Z, Devine H, Vukosavljecic T, Hugnh L, Lozanski G, Kefauver C, Plass C, Devine SM, Heerema NA, Murgo A, Chan KK, Grever MR, Byrd JC, Marcucci G. "Phase I study of decitabine alone or in combination with valproic acid in acute myeloid leukemia." J Clin Oncol. Vol. 25, no. 25. (September 2007.): 3884-3891.

Hamadani,M; Martin,L,L; Benson,D,M; Copelan,E,A; Devine,S,M; Hofmeister,C,C. "Central nervous system post-transplant lymphoproliferative disorder despite negative serum and spinal fluid Epstein-Barr virus DNA PCR." BONE MARROW TRANSPLANTATION. Vol. 39, no. 4. (February 2007.): 249-251.

Fong T, Trinkaus K, Adkins D, Vij R, Devine SM, Tomasson M, Goodnough LT, Lopez S, Graubert T, Shenoy S, DiPersio JF, Khoury HJ. "A randomized double-blind trial of hydroxychloroquine for the prevention of chronic fraft-versus-host disease after allogeneic peripheral blood stem cell transplantation." Biol Blood Marrow Transplant. Vol. 10, no. 13. (January 2007.): 1201-1206.

Hess DA, Bonde J, Craft TC, Wirthlin L, Hohm S, Lahey R, Todt LM, Dipersio JF, Devine SM, Nolta JA. "Human progenitor cells rapidly mobilized by AMD3100 repolulate NOD/SCID mice with increased frequency in comparison to cells from the same donor mobilized by granulocyte colony stimulating factor.." Biol Blood Marrow Transplant. Vol. 13, (April 2007.): 398-411.

Mehdi Hamadani, Patrick Elder, Farrukh Awan, David Krugh, William Blum, Thomas Lin, Leslie Andritsos, Thomas Bechtel, Kristie Blum, Rebecca Klisovic, and Steven M. Devine. "High Rates of Early Donor Chimerism and Low Risk of Chronic GVHD Can Be Achieved in Poor Risk Patients Undergoing Unrelated Donor Stem Cell Transplantation Using a Reduced Intensity Conditioning Regimen Incorporating Fludarabine, Busulfan, and Rabbit AT." Blood (ASH Annual Meeting Abstracts). Vol. 110, (November 2007.): 5080-.

Hamadani, M; Martin, L, K; Benson, D, M; Copelan, E, A; Devine, S, M; Hofmeister, C C. "Central nervous system post-transplant lymphoproliferative disorder despite negative serum and spinal fluid Epstein-Barr virus DNA PCR.." Bone marrow transplantation. Vol. 39, no. 4. (January 2007.): 249-51.

Hess,David,A; Bonde,Jesper; Craft,Timothy,C; Wirthlin,Louisa; Hohm,Sarah; Lahey,Ryan; Todt,Laura,M; DiPersio,John,F; Devine,Steven,M; Nolta,Jan,A. "Human progenitor cells rapidly mobilized by AMD3100 repopulate NOD/SCID mice with increased frequency in comparison to cells from the same donor mobilized by granulocyte colony stimulating factor." BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. Vol. 13, no. 4. (April 2007.): 398-411.

Benson, DM Jr, Smith MK, Devine SM.. "Successful therapy of chronic graft-versus-host disease manifesting as pure red cell aplasia with single-agent rituximab." Bone Marrow Transplant. Vol. 26, (November 2007.): -.

Cashen,A,F; Lazarus,H,M; Devine,S,M. "Mobilizing stem cells from normal donors: is it possible to improve upon G-CSF?." BONE MARROW TRANSPLANTATION. Vol. 39, no. 10. (May 2007.): 577-588.

Hamadani,Mehdi; Benson,Don,M; Lin,Thomas,S; Porcu,Pierluigi; Blum,Kristie,A; Devine,Steven,M. "High-dose therapy and autologous stem cell transplantation for follicular lymphoma undergoing transformation to diffuse large B-cell lymphoma." EUROPEAN JOURNAL OF HAEMATOLOGY. Vol. 81, no. 6. (December 2008.): 425-431.

Dubberke,Erik,R; Sadhu,Justin; Gatti,Robert; Reske,Kimberly,A; DiPersio,John,F; Devine,Steven,M; Fraser,Victoria,J. "Is diarrhea enough to assess the severity of Clostridium difficile - Associated disease? Reply." INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY. Vol. 29, no. 2. (February 2008.): 189-190.

Dubberke ER, Sadhu J, Gatti R, Reske KA, Dipersio JF, Devine SM. "Reply to Jaber et al." Infect Control Hosp Epidemiol. Vol. 29, no. (2). (February 2008.): 189-190.

Benson,D,M; Smith,M,K; Krugh,D; Devine,S,M. "Successful therapy of chronic graft-versus-host disease manifesting as pure red cell aplasia with single-agent rituximab." BONE MARROW TRANSPLANTATION. Vol. 41, no. 6. (March 2008.): 595-596.

Klisovic RB, Blum W, Wei X, Liu S, Liu Z, Xie Z, Vukosavljevic T, Kefauver C, Huynh L, Pang J, Zwiebel JA, Devine S, Byrd JC, Grever MR, Chan K, Marcucci G.. "Phase I study of GTI-2040, an antisense to ribonucleotide reductase, in combination with high-dose cytarabine in patients with acuite myeloid leukemia.." Clin Cancer Res. Vol. 12, no. 14. (June 2008.): 32889-95.

Hamadani,Mehdi; Awan,Farrukh,T; Devine,Steven,M. "The impact of HMG-CoA reductase inhibition on the incidence and severity of graft-versus-host disease in patients with acute leukemia undergoing allogeneic transplantation." BLOOD. Vol. 111, no. 7. (April 2008.): 3901-3902.

Wildes,Tanya,M; Augustin,Kristan,M; Sempek,Diane; Zhang,Qin,Jean; Vij,Ravi; DiPersio,John,F; Devine,Steven,M. "Comorbidities, not age, impact outcomes in autologous stem cell transplant for relapsed non-Hodgkin lymphoma." BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. Vol. 14, no. 7. (July 2008.): 840-846.

Hamadani,Mehdi; Hofmeister,Craig,C; Jansak,Buffy; Phillips,Gary; Elder,Patrick; Blum,William; Penza,Sam; Lin,Thomas,S; Klisovic,Rebecca; Marcucci,Guido; Farag,Sherif,S; Devine,Steven,M. "Addition of infliximab to standard acute graft-versus-host disease prophylaxis following allogeneic peripheral blood cell transplantation." BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. Vol. 14, no. 7. (July 2008.): 783-789.

Klisovic,Rebecca,B; Bium,William; Wei,Xiaohui; Liu,Shujun; Liu,Zhongfa; Xie,Zhiliang; Vukosavljevic,Tamara; Kefauver,Cheryl; Huynh,LeNguyen; Pang,Jiuxia; Zwiebel,James,A; Devine,Steven; Byrd,John,C; Grever,Michael,R; Chan,Kenneth; Marcucci,Guido. "Phase I study of GTI-2040, an antisense to ribonucleotide reductase, in combination with high-dose cytarabine in patients with acute myeloid leukemia." CLINICAL CANCER RESEARCH. Vol. 14, no. 12. (June 2008.): 3889-3895.

Hamadani,Mehdi; Awan,Farrukh,T; Elder,Patrick; Lin,Thomas,S; Porcu,Peirluigi; Blum,Kristie,A; Devine,Steven,M. "Allogeneic hematopoietic stem cell transplantation for peripheral T cell lymphomas; Evidence of graft-versus-t cell lymphoma effect." BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. Vol. 14, no. 4. (April 2008.): 480-483.

Devine,Steven,M; Vij,Ravi; Rettig,Michael; Todt,Laura; McGlauchlen,Kiley; Fisher,Nicholas; Devine,Hollie; Link,Daniel,C; Calandra,Gary; Bridger,Gary; Westervelt,Peter; DiPersio,John,F. "Rapid mobilization of functional donor hematopoietic cells without G-CSF using AMD3100, an antagonist of the CXCR4/SDF-1 interaction." BLOOD. Vol. 112, no. 4. (August 2008.): 990-998.

Hamadani M, Awan FT, Elder P, Lin TS, Porcu P, Benson DM, Blum KA, Devine SM. "Feasibility of allogeneic hematopoietic stem cell transplantation for follicular lymphoma undergoing transformation to diffuse large B-cell lymphoma." Leukemia and Lymphoma. Vol. 10, no. 49. (January 2008.): 1893-1898.

Hamadani,M; Benson,D,M; Blum,W; Garzon,R; Devine,S,M. "Pulmonary Nocardia and Aspergillus co-infection in a patient with chronic graft-versus-host disease." TRANSPLANT INFECTIOUS DISEASE. Vol. 10, no. 1. (February 2008.): 24-26.

Hamdani M, Hofmeister CC, Jansak B, Phillips G, Elder P, Blum W, Penza S, Lin TS, Klisovic R, Marcucci G, Farag SS, Devine SM. "Addition of infliximab to standard acute graft-versus-host disease prophylaxis following allogeneic peripheral blood cell transplantation." Biol Blood Marrow Transplant. Vol. 14, no. 7. (July 2008.): 783-789.

Hamandani M, Benson Jr DM, Lin TS, Porcu, Blum KA, Devine SM.. "High-dose therapy and autologous stem cell transplantation for follicular lymphoma undergoing transformation to diffuse larbe B-cell lymphoma.." Eur J Haematol. no. Epub ahead of print. (September 2008.): -.

Hamadani M, Awan FT, Elder P, Lin TS, Porcu P, Blum KA, Devine SM. "Allogeneic hematopoietic stem cell transplantation for peripheral T cell lymphomas; evidence of graft-versus-T cell lymphoma effect." Biol Blood Marrow Transplant. Vol. 14, no. 4. (April 2008.): 480-483.

Devine SM, Vij R, Rettig M, Todt L, McGlauchlen K, Fisher N, Devine H, Link DC, Calandra G, Bridger G, Wetervelt P, Dipersio JF. "Rapid mobilization of functional donor hematopoietic cells without G-CSF using plerixafor, an antagonist of the CXCR4/SDF-1 interaction." Blood. Vol. 21, (April 2008.): -.

Wildes TM, Augustin KM, Sempek D, Zhang QJ, Vij R, Dipersio JF, Devine SM. "Comorbidities, not age, impact outcomes in autologous stem cell transplant for relapsed non-Hodgkin lymphoma." Biol Blood Marrow Transplant. Vol. 14, no. 7. (July 2008.): 840-846.

Hamadani M, Awan FT, Devine SM. "The impact of HMG-CoA reductase inhibition on the incidence and severity of graft-versus-host disease in patients with acute leukemia undergoing allogeneic transplantation." Blood. Vol. 111, no. 7. (April 2008.): 3901-3902.

O'Brien S, Berman E, Borghaei H, Deangelo DJ, Devetten MP, Devine S, Erba HP, Gotlib J, Jagasia M, Moore JO, Mughal T, Pinilla-Ibzrz, Radich JP, Shah Md NP, Shami PJ, Smith BD, Snyder DS, Tallman MS, Talpaz M, Wetzler M.. "NCCN clinical practice guidelines in oncology: chronic myelogenous leukemia.." JNCCN. Vol. 9, no. 7. (October 2009.): 984-1023.

Hamadani M, Blum W, Phillips G, Elder P, Andritsos L, Hofmeister C, O'Donnell L, Klisovic R, Penza S, Garzon R, Krugh D, Lin T, Benson DM, Byrd JC, Marcucci G, Devine SM.. "Improved non-relapse mortality and infection rate with lower dose of antithymocyte globulin in patients undergoing reduced intensity conditioning allogeneic transplantation for hematologic malignancies.." Biol Blood Marrow Transplant 2009. Vol. 11, no. 15. (November 2009.): 1422-30.

Blum KA, Hamadani M, Phillips GS, Lozanski G, Johnson AJ, Lucas DM, Smith LL, Baiocchi R, Lin TS, Porcu P, Devine SM, Byrd JC.. "Prolonged myelosuppression with clofarabine in the treatment of patients with relapsed or refractory, aggressive non-Hodgkin lymphoma.." Leuk Lymphoma. Vol. 3, no. 50. (March 2009.): 349-356.

Hamadani,Mehdi; Devine,Steven,M. "Reduced-intensity conditioning allogeneic stem cell transplantation in HIV patients with hematologic malignancies: yes, we can." BLOOD. Vol. 114, no. 12. (September 2009.): 2564-2566.

Anderson,Kenneth,C; Alsina,Melissa; Bensinger,William; Biermann,Sybil; Chanan-Khan,Asher; Cohen,Adam,D; Devine,Steven; Djulbegovic,Benjamin; Gasparetto,Cristina; Huff,Carol,Ann; Jagasia,Madan; Medeiros,Bruno,C; Meredith,Ruby; Raje,Noopur; Schriber,Jeffrey; Singhal,Seema; Somlo,George; Stockerl-Goldstein,Keith; Tricot,Guido; Vose,Julie,M; Weber,Donna; Yahalom,Joachim; Yunus,Furhan. "Multiple Myeloma." JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK. Vol. 7, no. 9. (October 2009.): 908-942.

Blum,Kristie,A; Hamadani,Mehdi; Phillips,Gary,S; Lozanski,Gerard; Johnson,Amy,J; Lucas,David,M; Smith,Lisa,L; Baiocchi,Robert; Lin,Thomas,S; Porcu,Pierluigi; Devine,Steven,M; Byrd,John,C. "Prolonged myelosuppression with clofarabine in the treatment of patients with relapsed or refractory, aggressive non-Hodgkin lymphoma." LEUKEMIA & LYMPHOMA. Vol. 50, no. 7. (January 2009.): 1232-1234.

Hamadani,Mehdi; Blum,William; Phillips,Gary; Elder,Patrick; Andritsos,Leslie; Hofmeister,Craig; O'Donnell,Lynn; Klisovic,Rebecca; Penza,Sam; Garzon,Ramiro; Krugh,David; Lin,Thomas; Bechtel,Thomas; Benson,Don,M; Byrd,John,C; Marcucci,Guido; Devine,Steven,M. "Improved Nonrelapse Mortality and Infection Rate with Lower Dose of Antithymocyte Globulin in Patients Undergoing Reduced-Intensity Conditioning Allogeneic Transplantation for Hematologic Malignancies." BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. Vol. 15, no. 11. (November 2009.): 1422-1430.

Hamadani,Mehdi; Benson,Don,M; Hofmeister,Craig,C; Elder,Patrick; Blum,William; Porcu,Pierluigi; Garzon,Ramiro; Blum,Kristie,A; Lin,Thomas,S; Marcucci,Guido; Devine,Steven,M. "Allogeneic Stem Cell Transplantation for Patients with Relapsed Chemorefractory Aggressive Non-Hodgkin Lymphomas." BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. Vol. 15, no. 5. (May 2009.): 547-553.

Anderson,Kenneth,C; Alsina,Melissa; Bensinger,William; Biermann,J,Sybil; Chanan-Khan,Asher; Cohen,Adam,D; Devine,Steven; Djulbegovic,Benjamin; Gasparetto,Cristina; Huff,Carol,Ann; Jagasia,Madan; Medeiros,Bruno,C; Meredith,Ruby; Raje,Noopur; Schriber,Jeffrey; Singhal,Seema; Somlo,George; Stockerl-Goldstein,Keith; Tricot,Guido; Vose,Julie,M; Weber,Donna; Yahalom,Joachim; Yunus,Furhan. "NCCN clinical practice guidelines in oncology: multiple myeloma.." Journal of the National Comprehensive Cancer Network. Vol. 7, no. 9. (October 2009.): 908-942.

Hamadni M, Benson DM Jr, Hofmeister CC, Elder P, Blum W, Porcu P, Garzon R, Blum KA, Lin TS, Marcucci G, Devine SM.. "Allogeneic stem cell transplantation for patients with relapsed chemorefractory aggressive non-Hodgkin's lymphomas.." Biol Blood Marrow Transplant. Vol. 5, no. 15. (March 2009.): 547-553.

Blum,Kristie,A; Hamadani,Mehdi; Phillips,Gary,S; Lozanski,Gerard; Johnson,Amy,J; Lucas,David,M; Smith,Lisa,L; Baiocchi,Robert; Lin,Thomas,S; Porcu,Pierluigi; Devine,Steven,M; Byrd,John,C. "Prolonged myelosuppression with clofarabine in the treatment of patients with relapsed or refractory, aggressive non-Hodgkin lymphoma." LEUKEMIA & LYMPHOMA. Vol. 50, no. 3. (January 2009.): 349-356.

Blum,Kristie,A; Hamadani,Mehdi; Phillips,Gary,S; Lozanski,Gerard; Johnson,Amy,J; Lucas,David,M; Smith,Lisa,L; Baiocchi,Robert; Lin,Thomas,S; Porcu,Pierluigi; Devine,Steven,M; Byrd,John,C. "Prolonged myelosuppression with clofarabine in the treatment of patients with relapsed or refractory, aggressive non-Hodgkin lymphoma." LEUKEMIA & LYMPHOMA. Vol. 50, no. 7. (January 2009.): 1232-1234.

Anderson,Kenneth,C; Alsina,Melissa; Bensinger,William; Biermann,J,Sybil; Chanan-Khan,Asher; Cohen,Adam,D; Devine,Steven; Djulbegovic,Benjamin; Gasparetto,Cristina; Huff,Carol,Ann; Jagasia,Madan; Medeiros,Bruno,C; Meredith,Ruby; Raje,Noopur; Schriber,Jeffrey; Singhal,Seema; Somlo,George; Stockerl-Goldstein,Keith; Tricot,Guido; Vose,Julie,M; Weber,Donna; Yahalom,Joachim; Yunus,Furhan. "NCCN clinical practice guidelines in oncology: multiple myeloma.." Journal of the National Comprehensive Cancer Network : JNCCN. Vol. 7, no. 9. (October 2009.): 908-942.

Hamadani,M; Craig,M; Awan,F,T; Devine,S,M. "How we approach patient evaluation for hematopoietic stem cell transplantation." BONE MARROW TRANSPLANTATION. Vol. 45, no. 8. (August 2010.): 1259-1268.

Benson DM Jr, Panzner K, Hamadani M, Hofmeister CC, Bakan CE, Smith MK, Elder P, Krugh D, O'Donnell L, Devine S.. "Effects of induction with novel agents versus conventional chemotherapy on mobilization and autologous stem cell transplant outcomes in multiple myeloma.." Leukemia & Lymphoma. Vol. (2), no. 51. (February 2010.): 243-51.

Devine,Steven,M. "Hematopoietic Stem Cell Transplantation for Cutaneous T-Cell Lymphoma." CLINICAL LYMPHOMA MYELOMA & LEUKEMIA. Vol. 10, (September 2010.): S96-S98.

Blum W, Garzon R, Klisovic RB, Schwind S, Walker A, Geyer S, Liu S, Havelange V, Becker H, Schaaf L, Mickle J, Devine H, Kefauver C, Devine S, Chan KK, Heerema NA, Bloomfield CD, Grever MR, Byrd JC, Villalona-Calero M, Croce CM, Marcucci G.. "Clinical Response and miR-29b predictive significance in older AML patients treated with a 10-day schedule of decitabine.." Proc Natl Acad Sci USA.. Vol. 16, no. 107. (April 2010.): 7473-7478.

Blum KA, Liu A, Lucas DM, Chen P, Xie Z, Baiocchi R, Benson DM, Devine SM, Jones J, Andritsos L, Flynn J, Plass C, Marcucci G, chan KK, Grever MR, Byrd JC.. "Phase I trial of low dose decitabine targeting DNA hypermethylation in patents with chronic lymphocytic leukaemia and non-Hodgkin lymphoma: dose-limiting myelosuppression without evidence of DNA hypomethylation.." British Journal Haematology. Vol. 2, no. 150. (April 2010.): 189-195.

Christian B, Zhao W, Hamadani M, Sotomayor EM, Navarro W, Devine S, Racke F, Blum KA.. "Mantle Cell Lymphoma 12 Years After Allogeneic Bone Marrow Transplantation Occurring Simultaneously in Recipient and Donor.." Journal of Clinical Oncology. Vol. (31), no. 28. (November 2010.): e629-32.

Hamadani M, Craig M, Awan FT, Devine S.. "How we approach patient evaluation for hematopoietic stem cell transplantation.." Bone Marrow Transplant. Vol. (8), no. 45. (August 2010.): 1259-68.

Ganadabu Nm Craig M, Awan FT, Devine S.. "How we approach patient evaluation for hematopoietic stem cell transplantation.." Bone Marrow Transplantation. Vol. 8, no. 45. (August 2010.): 1259-68.

Blum,William; Garzon,Ramiro; Klisovic,Rebecca,B; Schwind,Sebastian; Walker,Alison; Geyer,Susan; Liu,Shujun; Havelange,Violaine; Becker,Heiko; Schaaf,Larry; Mickle,Jon; Devine,Hollie; Kefauver,Cheryl; Devine,Steven,M; Chan,Kenneth,K; Heerema,Nyla,A; Bloomfield,Clara,D; Grever,Michael,R; Byrd,John,C; Villalona-Calero,Miguel; Croce,Carlo,M; Marcucci,Guido. "Clinical response and miR-29b predictive significance in older AML patients treated with a 10-day schedule of decitabine." PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. Vol. 107, no. 16. (April 2010.): 7473-7478.

Ballen KK, Shrestha S, Sobocinski KA, Zhang MJ, Bashey A, Bolwell BJ, Cervantes F, Devine S, Gale RP, Gupta V, Hahn TE, Hogan WJ, Kroger N, Litzow MR, Marks DI, Maziarz RT, McCarthy PL, Schiller G, Schouten HC, Roy V, Wiernik PH, Horowitz MM, Giralt SA, Arora M.. "Outcome of transplantation for myelofibrosis.." Biol Blood Marrow Transplant. Vol. (3), no. 16. (March 2010.): 358-67.

Benson,Don,M; Bakan,Courtney,E; Mishra,Anjali; Hofmeister,Craig,C; Efebera,Yvonne; Becknell,Brian; Baiocchi,Robert,A; Zhang,Jianying; Yu,Jianhua; Smith,Megan,K; Greenfield,Carli,N; Porcu,Pierluigi; Devine,Steven,M; Rotem-Yehudar,Rinat; Lozanski,Gerard; Byrd,John,C; Caligiuri,Michael,A. "The PD-1/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti-PD-1 antibody." BLOOD. Vol. 116, no. 13. (September 2010.): 2286-2294.

Christian,Beth; Zhao,Weiqiang; Hamadani,Mehdi; Sotomayor,Eduardo,M; Navarro,Willis. "Mantle Cell Lymphoma 12 Years After Allogeneic Bone Marrow Transplantation Occurring Simultaneously in Recipient and Donor." JOURNAL OF CLINICAL ONCOLOGY. Vol. 28, no. 31. (November 2010.): E629-E632.

Blum,William; Klisovic,Rebecca,B; Becker,Heiko; Yang,Xiaoxia; Rozewski,Darlene,M; Phelps,Mitch,A; Garzon,Ramiro; Walker,Alison; Chandler,Jason,C; Whitman,Susan,P; Curfman,John; Liu,Shujun; Schaaf,Larry; Mickle,Jon; Kefauver,Cheryl; Devine,Steven,M; Grever,Michael,R; Marcucci,Guido; Byrd,John,C. "Dose Escalation of Lenalidomide in Relapsed or Refractory Acute Leukemias." JOURNAL OF CLINICAL ONCOLOGY. Vol. 28, no. 33. (November 2010.): 4919-4925.

Blum,Kristie,A; Liu,Zhongfa; Lucas,David,M; Chen,Ping; Xie,Zhiliang; Baiocchi,Robert; Benson,Donald,M; Devine,Steven,M; Jones,Jeffrey; Andritsos,Leslie; Flynn,Joseph; Plass,Christoph; Marcucci,Guido; Chan,Kenneth,K; Grever,Michael,R; Byrd,John,C. "Phase I trial of low dose decitabine targeting DNA hypermethylation in patients with chronic lymphocytic leukaemia and non-Hodgkin lymphoma: dose-limiting myelosuppression without evidence of DNA hypomethylation." BRITISH JOURNAL OF HAEMATOLOGY. Vol. 150, no. 2. (July 2010.): 189-195.

Dunavin,Neil; Habib,Joyce; Phillips,Gary; Elder,Patrick; Tranovich,Meaghan; Benson,Don,M; Hofmeister,Craig,C; Byrd,John,C; Devine,Steven,M; Efebera,Yvonne. "Early Versus Delayed Autologous Stem Cell Transplant In Patients Receiving Novel Therapies for Multiple Myeloma." BLOOD. Vol. 116, no. 21. (November 2010.): 1466-1467.

Benson,Don,M; Panzner,Kathryn; Hamadani,Mehdi; Hofmeister,Craig,C; Bakan,Courtney,E; Smith,Megan,K; Elder,Pat; Krugh,David; O'Donnell,Lynn; Devine,Steven,M. "Effects of induction with novel agents versus conventional chemotherapy on mobilization and autologous stem cell transplant outcomes in multiple myeloma." LEUKEMIA & LYMPHOMA. Vol. 51, no. 2. (February 2010.): 243-251.

Benson DM Jr, Panzner K, Hamadani M, Hofmeister CC, Bakan CE, Smith MK, Elder P, Krugh D, O'Donnell L, Devine S.. "Effects of induction with novel agents versus conventional chemotherapy on mobilization and autologous stem cell transplant outcomes in multiple myeloma.." Leuk Lymphoma. Vol. 2, no. 51. (February 2010.): 243-251.

Ballen KK, Smriti S, Sobocinski KA, Zhang MJ, Bashey A, Bolwell BJ, Cervantes F, Devine SM, Gale RP, Gupta V, Hahn TE, Hogan WJ, Kroger N, Litzow MR, Marks DI, Maziarz RT, McCarthy PL, Schiller G, Schouten HC, Roy V, Wiernik PH, Horowitz MM, Giralt SA, Ar. "Outcome of Transplantation for Myelofibrosis." Blood. Vol. 3, no. 16. (March 2010.): 358-367.

Blum W, Garzon R, Klisovic RB, Schwind S, Walker A, Geyer S, Liu S, Havelange V, Becker H, Schaaf L, Mickle J, Devine H, Kefauver C, Devine S, Chan KK, Heerema NA, Bloomfield CD, Grever MR, Byrd JC, Villalona-Calero M, Croce CM, Marcucci G.. "Clinical response and miR-29b predictive significance in older AML patients treated with a 10-day schedule of decitabine.." Proc Natl Acad Sci U S A. Vol. (16), no. 107. (April 2010.): 7473-8.

Benson DM Jr, Bakan CE, Mishra A, Hofmeister CC, Efebera Y, Becknell B, baiocchi RA, Zhang J, Yu J, Smith MK, Greenfield CN, Porcu P, Devine SM, Rotem-Yehudar R, Lozanski G, Byrd JC, Caligiuri MA.. "The PD-1/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel, monoclonal anti-PD-1 antibody.." Blood. Vol. (13), no. 116. (September 2010.): 2286-2294.

Blum,William; Phelps,Mitch,A; Klisovic,Rebecca,B; Rozewski,Darlene,M; Ni,Wenjun; Albanese,Katie,A; Rovin,Brad; Kefauver,Cheryl; Devine,Steven,M; Lucas,David,M; Johnson,Amy; Schaaf,Larry,J; Byrd,John,C; Marcucci,Guido; Greyer,Michael,R. "Phase I clinical and pharmacokinetic study of a novel schedule of flavopiridol in relapsed or refractory acute leukemias." HAEMATOLOGICA-THE HEMATOLOGY JOURNAL. Vol. 95, no. 7. (July 2010.): 1098-1105.

Blum W, Phelps MA, Klisovic RB, Rozewski DM, Ni W, Albanese KA, Rovin B, Kefauver C,Devine S, Lucas DM, Johnson A, Schaaf LJ, Byrd JC, Marcucci G, Grever MR>. "Phase I clinical and pharmacokinetic study of a novel schedule of flavopiridol in relapsed or refractory acute leukemias.." Haematologica. Vol. (7), no. 95. (July 2010.): 1098-1105.

Blum KA, Liu Z, Lucas DM, Chen P, Xie Z, Baiocchi R, Benson DM, Devine S, Jones J, Andritsos L, Flynn J, Marcucci G, Chan KK, Grever MR, Byrd JC.. "Phase I trial of low dose decitabine targeting DNA hypermethylation in patients chronic lymphocytic leukaemia and non-Hodgkin lymphoma: dose-limiting myelosuppression without evidence of DNA hypomethylation.." Br J Haematol. Vol. (2), no. 150. (July 2010.): 189-95.

Bashey A, Owzar K, Johnson JL, Edwards PS, Kelly M, Baxter-Lowe LA, Devine S, Farag S, Hurd D, Ball E, McCarthy P, Lister J, Shea TC, Linker C.. "Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell transplantation for Patients with Hematologic Malignancies Who Relapse following Autologous Transplantation: A Multi-Institutional Prospective Study from the Cancer and Leukemia Group B (CALGB trial 100002).." Biol Blood Marrow Transplant.. no. Epub ahead of publication. (July 2010.): -.

Blum,William; Phelps,Mitch,A; Klisovic,Rebecca,B; Rozewski,Darlene,M; Ni,Wenjun; Albanese,Katie,A; Rovin,Brad; Kefauver,Cheryl; Devine,Steven,M; Lucas,David,M; Johnson,Amy; Schaaf,Larry,J; Byrd,John,C; Marcucci,Guido; Greyer,Michael,R. "Phase I clinical and pharmacokinetic study of a novel schedule of flavopiridol in relapsed or refractory acute leukemias." HAEMATOLOGICA-THE HEMATOLOGY JOURNAL. Vol. 95, no. 7. (July 2010.): 1098-1105.

Soiffer,Robert,J; LeRademacher,Jennifer; Ho,Vincent; Kan,Fangyu; Artz,Andrew; Champlin,Richard,E; Devine,Steven; Isola,Luis; Lazarus,Hillard,M; Marks,David,I; Porter,David,L; Waller,Edmund,K; Horowitz,Mary,M; Eapen,Mary. "Impact of immune modulation with anti-T-cell antibodies on the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies." BLOOD. Vol. 117, no. 25. (June 2011.): 6963-6970.

Hamadani,M; Craig,M; Abraham,J; Tse,W; Cumpston,A; Gibson,L,F; Remick,S,C; Leadmon,S; Elder,P; Hofmeister,C; Penza,S; Andritsos,L; Blum,W; Benson,D,M; Devine,S,M. "HIGHER BUSULFAN DOSE INTENSITY DOES NOT IMPROVE OUTCOMES OF PATIENTS UNDERGOING ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION (AHCT) FOLLOWING FLUDARABINE/BUSULFAN/ATG (FBA)-BASED REDUCED TOXICITY CONDITIONING (RTC)." BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. Vol. 17, no. 2. (February 2011.): S306-S306.

Anderson,K,C. "Multiple Myeloma (vol 9, pg 1146, 2011)." JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK. Vol. 9, no. 12. (December 2011.): XXV-XXV.

Liu,Kechang; Anthony,Bryan,A; Yearsly,Martha,M; Hamadani,Mehdi; Gaughan,Alice; Wang,Jiao-Jing; Devine,Steven,M; Hadley,Gregg,A. "CD103 Deficiency Prevents Graft-versus-Host Disease but Spares Graft-versus-Tumor Effects Mediated by Alloreactive CD8 T Cells." PLOS ONE. Vol. 6, no. 7. (July 2011.): e21968-.

Devine,Steven,M; Carter,Shelly; Soiffer,Robert,J; Pasquini,Marcelo,C; Hari,Parameswaran,N; Stein,Anthony; Lazarus,Hillard,M; Linker,Charles; Stadtmauer,Edward,A; Alyea,Edwin,P; Keever-Taylor,Carolyn,A; O'Reilly,Richard,J. "Low Risk of Chronic Graft-versus-Host Disease and Relapse Associated with T Cell-Depleted Peripheral Blood Stem Cell Transplantation for Acute Myelogenous Leukemia in First Remission: Results of the Blood and Marrow Transplant Clinical Trials Network Protocol 0303." BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. Vol. 17, no. 9. (September 2011.): 1343-1351.

Anderspm LC. A;soma <. Bemsomger W. boer,amm KS. Cjamam=Khan A, cohen AD, Devine S, Djulbegovic B, Faber EA Jr, Gasparetto C, Huff CA, Kassim A, Medeiros BC, Meredith R, Raje N, Schriber J, Singhal S, Somlo G, Stockerl-Goldstein K, Treon SP, Tricot G, Weber DM, Yahalom J, Yunus F. "Mutiple Myeloma. National Comprehensive Cancer Network." J Natl Compr Canc Netw. Vol. 9, no. 10. (October 2011.): 1146-83.

Devine,Steven,M. "Can we build a better allograft?." BLOOD. Vol. 118, no. 25. (December 2011.): 6478-6479.

Soiffer RJ, Lerademacher J, Ho V, Kan F, Artz A, Champlin RE, Devine S, Isola L, Lazarus HM, Marks DI, Porter DL, Waller EK, Horowitz MM, Eapen M.. "Impact of immune modulation with anti-T cell antibodies on outcomes of reduced intensity allogeneic hematopoietic cell transplantation for hematologic malignancies.." Blood. Vol. (25), no. 117. (June 2011.): 6963-6970.

Devine S. "Impact of immune modulation with anti-T-cell antibodies on the outcome of red intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies.." Blood. Vol. 25, no. 117. (June 2011.): 6963-6970.

Anderson,Kenneth,C; Alsina,Melissa; Bensinger,William; Biermann,J,Sybil; Chanan-Khan,Asher; Cohen,Adam,D; Devine,Steven; Djulbegovic,Benjamin; Faber,Edward,A; Gasparetto,Cristina; Huff,Carol,Ann; Kassim,Adetola; Medeiros,Bruno,C; Meredith,Ruby; Raje,Noopur; Schriber,Jeffrey; Singhal,Seema; Somlo,George; Stockerl-Goldstein,Keith; Treon,Steven,P; Tricot,Guido; Weber,Donna,M; Yahalom,Joachim; Yunus,Furhan. "Multiple Myeloma." JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK. Vol. 9, no. 10. (October 2011.): 1146-1183.

Bashey,Asad; Owzar,Kouros; Johnson,Jeffrey,L; Edwards,Peggy,S; Kelly,Michael; Baxter-Lowe,Lee-Ann; Devine,Steven; Farag,Sherif; Hurd,David; Ball,Edward; McCarthy,Philip; Lister,John; Shea,Thomas,C; Linker,Charles. "Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation for Patients with Hematologic Malignancies Who Relapse following Autologous Transplantation: A Multi-institutional Prospective Study from the Cancer and Leukemia Group B (CALGB trial 100002)." BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. Vol. 17, no. 4. (April 2011.): 558-565.

Hamadani,Mehdi; Craig,Michael; Phillips,Gary,S; Abraham,Jame; Tse,William; Cumpston,Aaron; Gibson,Laura; Remick,Scot,C; Bunner,Pamela; Leadmon,Sonia; Elder,Patrick; Hofmeister,Craig; Penza,Sam; Efebera,Yvonne; Andritsos,Leslie; Garzon,Ramiro; Benson,Don,M; Blum,William; Devine,Steven,M. "Higher busulfan dose intensity does not improve outcomes of patients undergoing allogeneic haematopoietic cell transplantation following fludarabine, busulfan-based reduced toxicity conditioning." HEMATOLOGICAL ONCOLOGY. Vol. 29, no. 4. (December 2011.): 202-210.

Hamadani M, Craig M, Phillips GS, Abraham J, Tse W, Cumpston A, Gibson L, Remick SC, Bunner P, Leadmon S, Elder P, Hofmeister C, Penza S, Efebera Y, Andritsos L, Garzon R, Benson DM Jr, Blum W, Devine S.. "Higher busulfan dose intensity does not improve outcomes of patients undergoing allogeneic haematopoietic cell transplantation following fludarabine, busulfan-based reduced toxicity conditioning.." Hematol Oncol. Vol. doiL10.1002/hon. 985. Epub ahead of print, (February 2011.): -.

Devine S, Carter S, Soiffer RJ, Pasquini MC, Hari PN, Stein A, Lazarus HM, Linker C, Stadtmauer EA, Alyea EP 3rd, Keever-Taylor CA, O'Reilly RJ.. "Low Risk of Chronic Grant-versus-Host Disease and Relapse Associated with T Cell-Depleted Peripheral Blood Stem Cell Transplantation for Acute Myelogenous Leukemia in First Remission: Results of the Blood and Marrow Transplant Clinical Trials Network Protocol 0303.." Biol Blood Marrow Transplant. no. Epub ahead of print. (February 2011.): -.

Brunstein CG, Fuchs EJ, Carter SL, Karanes C, Costa LJ, Wu J, Devine S, Wingard JR, Aljitawi OS, Cutler CS, Jagasia MH, Ballen KK, Eapen M, O'Donnell PV.. "Alternative donor transplantation: results of parallel phase II trials using HLA-mismatched related bone marrow or unrelated umbilical cord blood grafts.." Blood. no. E pub ahead of print.. (April 2011.): -.

Bashey,Asad; Owzar,Kouros; Johnson,Jeffrey,L; Edwards,Peggy,S; Kelly,Michael; Baxter-Lowe,Lee-Ann; Devine,Steven; Farag,Sherif; Hurd,David; Ball,Edward; McCarthy,Philip; Lister,John; Shea,Thomas,C; Linker,Charles. "Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation for Patients with Hematologic Malignancies Who Relapse following Autologous Transplantation: A Multi-institutional Prospective Study from the Cancer and Leukemia Group B (CALGB trial 100002)." BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. Vol. 17, no. 4. (April 2011.): 558-565.

Bashey A, Owzar K, Johnson JL, Edwards PS, Kelly M, Baxter-Lowe LA, Devine S, Farag S, Hurd D, Ball E, McCarthy P, Lister J, Shea TC, Linker C.. "Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation for Patients with Hematologic Malignancies Who Relapse Following autologous Transplantation: A Multi-institutional Prospective Study from the Cancer and Leukemia Group B (CALGB Trial 100002).." Biol Blood Marrow Transplant. Vol. (4), no. 17. (April 2011.): 558-565.

Christian B, Zhao W, Hamadani M, Sotomayor EM, Navarro W, Devine S, Racke F, Blum KA.. "Mantle cell lymphoma 12 years after allogeneic bone marrow transplantation occurring simultaneously in recipient and donor.." J Clin Oncol. Vol. 31, no. 28. (November 2011.): 629-632.

Mahindra A, Bolwell BJ, Rybicki L, Elder P, Kalaycio M, Dean R, Avalos B, Sobecks R, Tench S, Andresen S, Pohlman B, sweetenham J, Devine S, Copelan E.. "Etoposide plus G-CSF priming compared with G-CSF alone in patients with lymphoma improves mobilication without an increased risk of secondary myelodysplasia and leukemia.." Bone Marrow Transplant. no. E pub ahead of print.. (April 2011.): -.

Brunstein,Claudio,G; Fuchs,Ephraim,J; Carter,Shelly,L; Karanes,Chatchada; Costa,Luciano,J; Wu,Juan; Devine,Steven,M; Wingard,John,R; Aljitawi,Omar,S; Cutler,Corey,S; Jagasia,Madan,H; Ballen,Karen,K; Eapen,Mary; O'Donnell,Paul,V. "Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts." BLOOD. Vol. 118, no. 2. (July 2011.): 282-288.

Ranganathan,Parvathi; Heaphy,Catherine,EA; Costinean,Stefan; Stauffer,Nicole; Na,Caroline; Hamadani,Mehdi; Santhanam,Ramasamy; Mao,Charlene; Taylor,Patricia,A; Sandhu,Sukhinder; He,Gang; Shana'ah,Arwa; Nuovo,Gerard,J; Lagana,Alessandro; Cascione,Luciano; Obad,Susanna; Broom,Oliver; Kauppinen,Sakari; Byrd,John,C; Caligiuri,Michael; Perrotti,Danilo; Hadley,Gregg,A; Marcucci,Guido; Devine,Steven,M; Blazar,Bruce,R; Croce,Carlo,M; Garzon,Ramiro. "Regulation of acute graft-versus-host disease by microRNA-155.." Blood. Vol. 119, no. 20. (May 2012.): 4786-4797.

Mahindra,A; Bolwell,B,J; Rybicki,L; Elder,P; Kalaycio,M; Dean,R; Avalos,B; Sobecks,R; Tench,S; Andresen,S; Pohlman,B; Sweetenham,J; Devine,S; Copelan,E. "Etoposide plus G-CSF priming compared with G-CSF alone in patients with lymphoma improves mobilization without an increased risk of secondary myelodysplasia and leukemia." BONE MARROW TRANSPLANTATION. Vol. 47, no. 2. (February 2012.): 231-235.

Jaglowski SM, Ruppert AS, Heerema NA, Bingman A, Flynn JM, Grever MR, Jones JA, Elder P, Devine SM, Byrd JC, Andritsos LA.. "Complex karyotype predicts for inferior outcomes following reduced-intensity conditioning allogeneic transplant for chronic lymphocytic leukaemia.." Br J Haematol. Vol. E-pub, (July 2012.): n/a-.

O'Brien S, Abboud CN, Akhtari M, Altman J, Berman E, DeAngelo DJ, Devine S, Fathi AT, Gotlib J, Jagasia M, Moore JO, Pinilla-Ibarz J, Radich JP, Reddy VV, Shah NP, Shami PJ, Smith BD, Snyder DS, Wetzler M, Yunus F.. "National Comprehensive Cancer Network. Chronic myelogenous leukemia. Clinical practice guidelines in oncology." J Natl Compr Canc Network. Vol. 10, no. 1. (January 2012.): 64-110.

Tran J, Norder EE, Diaz PT, Phillips GS, Elder P, Devine SM, Wood KL. "Pulmonary Rehabilitation for Bronchiolitis Obliterans Syndrome after Hematopoietic Stem Cell Transplantation." Biol Blood Marrow Transplant. Vol. E pub, (January 2012.): n/a-.

Armand,Philippe; Kim,Haesook,T; Zhang,Mei-Jie; Perez,Waleska,S; Dal Cin,Paola,S; Klumpp,Thomas,R; Waller,Edmund,K; Litzow,Mark,R; Liesveld,Jane,L; Lazarus,Hillard,M; Artz,Andrew,S; Gupta,Vikas; Savani,Bipin,N; McCarthy,Philip,L; Cahn,Jean-Yves; Schouten,Harry,C; Finke,Juergen; Ball,Edward,D; AlJurf,Mahmoud,D; Cutler,Corey,S; Rowe,Jacob,M; Antin,Joseph,H; Isola,Luis,M; Di Bartolomeo,Paolo; Camitta,Bruce,M; Miller,Alan,M; Cairo,Mitchell,S; Stockerl-Goldstein,Keith; Sierra,Jorge; Savoie,M,Lynn; Halter,Joerg; Stiff,Patrick,J; Nabhan,Chadi; Jakubowski,Ann,A; Bunjes,Donald,W; Petersdorf,Effie,W; Devine,Steven,M; Maziarz,Richard,I; Bornhauser,Martin; Lewis,Victor,A; Marks,David,I; Bredeson,Christopher,N; Soiffer,Robert,J; Weisdorf,Daniel,J. "Classifying Cytogenetics in Patients with Acute Myelogenous Leukemia in Complete Remission Undergoing Allogeneic Transplantation: A Center for International Blood and Marrow Transplant Research Study." BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. Vol. 18, no. 2. (February 2012.): 280-288.

Weisdorf,Daniel; Cooley,Sarah; Devine,Steven; Fehniger,Todd,A; DiPersio,John; Anasetti,Claudio; Waller,Edmund,K; Porter,David; Farag,Sherif; Drobyski,William; DeFor,Todd; Haagenson,Michael; Curtsinger,Julie; Miller,Jeffrey. "T Cell-Depleted Partial Matched Unrelated Donor Transplant for Advanced Myeloid Malignancy: KIR Ligand Mismatch and Outcome.." Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. Vol. 18, no. 6. (June 2012.): 937-943.

McCarthy,Philip,L; Owzar,Kouros; Hofmeister,Craig,C; Hurd,David,D; Hassoun,Hani; Richardson,Paul,G; Giralt,Sergio; Stadtmauer,Edward,A; Weisdorf,Daniel,J; Vij,Ravi; Moreb,Jan,S; Callander,Natalie,Scott; Van Besien,Koen; Gentile,Teresa; Isola,Luis; Maziarz,Richard,T; Gabriel,Don,A; Bashey,Asad; Landau,Heather; Martin,Thomas; Qazilbash,Muzaffar,H; Levitan,Denise; McClune,Brian; Schlossman,Robert; Hars,Vera; Postiglione,John; Jiang,Chen; Bennett,Elizabeth; Barry,Susan; Bressler,Linda; Kelly,Michael; Seiler,Michele; Rosenbaum,Cara; Hari,Parameswaran; Pasquini,Marcelo,C; Horowitz,Mary,M; Shea,Thomas,C; Devine,Steven,M; Anderson,Kenneth,C; Linker,Charles. "Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma." NEW ENGLAND JOURNAL OF MEDICINE. Vol. 366, no. 19. (May 2012.): 1770-1781.

Keever-Taylor,Carolyn,A; Devine,Steven,M; Soiffer,Robert,J; Mendizabal,Adam; Carter,Shelly; Pasquini,Marcelo,C; Hari,Parameswaran,N; Stein,Anthony; Lazarus,Hillard,M; Linker,Charles; Goldstein,Steven,C; Stadtmauer,Edward,A; O'Reilly,Richard,J. "Characteristics of CliniMACS (R) System CD34-Enriched T Cell-Depleted Grafts in a Multicenter Trial for Acute Myeloid Leukemia-Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Protocol 0303." BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. Vol. 18, no. 5. (May 2012.): 690-697.

Devine,Steven,M. "Toward a More Rational Policy for Autologous Hematopoietic Stem Cell Mobilization." BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. Vol. 18, no. 10. (October 2012.): 1468-1470.

Shaughnessy P, Uberti J, Devine S, Maziarz RT, Vose J, Micallef I, Jacobsen E, McCarty J, Stiff P, Artz A, Ball ED, berryman R, dugan M, Joyce R, Hsu FJ, Johns D, McSweeney P.. "Plerixafor and G-CSF for autologous stem cell mobilization in patients with NHL, Hodgkin's lymphoma and multiple myeloma: results from the expanded access program." Bone Marrow Transplant. Vol. Epub ahead of print, (November 2012.): N/A-.

Bruce,Jarrod,T; Tran,Jerry,M; Phillips,Gary; Elder,Pat; Mastronarde,John,G; Devine,Steven,M; Hofmeister,Craig,C; Wood,Karen,L. "Chemotherapeutic Agents Increase the Risk for Pulmonary Function Test Abnormalities in Patients With Multiple Myeloma." CLINICAL LYMPHOMA MYELOMA & LEUKEMIA. Vol. 12, no. 5. (October 2012.): 325-329.

Pasquini MC, Devine S, Mendizabal A, Baden LR, Wingard JR, Lazarus HM, Appelbaum FR, Keever-Taylor CA, Horowitz MM, Carter S, O'Reilly RJ, Soiffer RJ on behalf of the Blood and Marrow Transplant Clinical Trials Network (BMT CTN). "Comparative Outcomes of Donor Graft CD34+ Selection and Immune Suppressive Therapy as Graft-vs-Host Disease Prophylaxis for Patients with Acute Myeloid Leukemia in Complete Remission undergoinging HLA-Matched Sibling Allogeneic Hematopoietic Cell Transplantation.." J Clin Oncol. Vol. 30, no. 26. (September 2012.): 3194-201.

Blum W, Schwind S, Tarighat SS, Geyer S, Eisfeld AK, Whitman S, Walker A, Klisovic R, Byrd JC, Santhanam R, Wang H, Curfman JP, Devine SM, Jacob S, Garr C, Kefauver C, Perrotti D, Chan KK, Bloomfield CD, Caligiuri MA, Grever MR, Garzon R, Marcucci G.. "Clinical and pharmacodynamic activity of bortezomib and decitabine in acute myeloid leukemia." Blood. Vol. E pub, (May 2012.): n/a-.

Anderson,Kenneth,C; Alsina,Melissa; Bensinger,William; Biermann,J,Sybil; Cohen,Adam,D; Devine,Steven; Djulbegovic,Benjamin; Faber,Edward,A; Hernandez-Ilizaliturri,Francisco; Huff,Carol,Ann; Kassim,Adetola; Krishnan,Amrita,Y; Medeiros,Bruno,C; Meredith,Ruby; Raje,Noopur; Schriber,Jeffrey; Singhal,Seema; Somlo,George; Stockerl-Goldstein,Keith; Treon,Steven,P; Tricot,Guido; Weber,Donna,M; Yahalom,Joachim; Yunus,Furhan; Kumar,Rashmi; Shead,Dorothy,A. "Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma, Version 2.2013 Featured Updates to the NCCN Guidelines." JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK. Vol. 10, no. 10. (October 2012.): 1211-1219.

Anderson,Kenneth,C; Alsina,Melissa; Bensinger,William; Biermann,J,Sybil; Cohen,Adam,D; Devine,Steven; Djulbegovic,Benjamin; Faber,Edward,A; Gasparetto,Cristina; Hernandez-Illizaliturri,Francisco; Huff,Carol,Ann; Kassim,Adetola; Krishnan,Amrita,Y; Liedtke,Michael; Meredith,Ruby; Raje,Noopur; Schriber,Jeffrey; Singhal,Seema; Somlo,George; Stockerl-Goldstein,Keith; Treon,Steven,P; Weber,Donna; Yahalom,Joachim; Yunus,Furhan; Shead,Dorothy,A; Kumar,Rashmi. "Multiple Myeloma, Version 1.2013 Featured Updates to the NCCN Guidelines." JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK. Vol. 11, no. 1. (January 2013.): 11-17.

Alousi AM, Le-Rademacher J, Saliba RM, Appelbaum FR, Artz A, Benjamin J, Devine SM, Kan F, Laughlin MJ, Lazarus HM, Liesveld J, Perales MA, Maziarz RT, Sabloff M, Waller EK, eapen M, Champlin RE. "Who is the better donor for older hematopoietic transplant recipients: an older-aged sibling or a young, matched unrelated volunteer?." Blood. Vol. Epub ahead of print, (January 2013.): Epub ahead of print-.

Poi MJ, Hofmeister CC, Phelps MA, Johnston JS, Edwards RB, Jansak BS, Lucas DS, Farag SS, Schaaf LJ, Dalton JT, Devine SM, Grever MR.. "Standard Pentostatin Dose Reductions in Renal Insufficiency ae not Adequate: Selected Patients with Steroid-Refractory Acute Graft-versus-Host Disease." Clinical Pharmacokinetics. -.

 

Reference Works

November 2005 Wildes TM, Augustin KM, Ravi V, Bartlett N, DiPersio NF, Devine SM.."Comparison of Outcomes in Elderly Patients with Non-Hodgkins Lymphoma Undergoing High-Dose Chemotherapy to Their Younger Counterparts: Greater Morbidity but No Significant Impact on Overall Survival." . : 2086
November 2005 Walter MJ, Ries RR, Li D, Shannon WJ, Payton J, Bloomfield CD, Mrozek K, ruppert AS, DiPersio J, Link D, Tomasson M, Graubert T, McLeod H, Devine SM, Watson M, Heath S, Baty J, Trinkaus K, Armstrong J, Mardis E, Wilson R, Selzer R, Richmond T, Eis P, Ley TJ.."Detection of Microdeletions and Amplifications in Primary Human Acute Myeloid Leukemia (AML) Genomes Using Ultradense Oligomer Tiling Path Arrays and Comparative Genomic Hybridization (CGH)." . : 2350
November 2005 Uy GL, Holt MS, Fisher NM, Devine SM, Tomasson MH, DiPersio JF, Ravi V.."Bortezomib Alters Peripheral Blood Lymphocyte Subsets in Patients with Multiple Myeloma." . : 2387
November 2005 Shachar P, Risher NM, Devine SM, Tomasson MH, DiPersio JF, Ravi V.."Bortezomib (Velcade) When Given Pretransplant and Once Weekly as Consolidation Therapy Following High Dose Chemotherapy (HDCT) Leads to High Rates of Reactivation of Varicella zoster Virus (VZV)." . : 3237
November 2005 Shachar P, Fisher NM, Gao F, Devine SM, Tomasson MH, DiPersio JF, Ravi V.."Once Weekly Bortezomib (Velcade) Preserves Bone Health by a Direct Effect on Osteoclast Function Independent of Its Effect on the Malignant Plasma Cells." . : 3458
November 2005 Hess DA, Wirthlin L, Craft TP, Bonde J, Lahey RW, Hohm SA, Herrbrich PE, DiPersio JF, Devine SM, Nolta JA.."Human CD34+Cells Mobilized by AMD3100Demonstrate EnhancedNOD/SCID Repopulating Function Compared to CD34+Cells Mobilized by Granulocyte Colony Stimulating Factor." . : 1962
November 2005 Fong T, Trinkaus K, Adkins DR, Ravi V, Devine S, Tomasson M, Goodnough LT, Graubert T, Shenoy S, DiPersio JF, Khoury HJ.."A Randomized, Double Blind Trial of Hydroxychloroquine for the Presention of Grant-ersus-Host Disease after Allogeneic Peripheral Blood Stem Cell Transplantation." . : 1800
November 2005 Devine SM, Andritsos LA, Todt L, Ravi V, Bonde J, Hess D, Nolta J, Link D, Bridger G, Calandra G, DiPersio JF.."A Pilot Study Evaluating the Safety and Efficacy of AMD3100 for the Mobilization and Transplantation of HLA-Matched Sibling Donor Hematopoietic Stem Cells in Patients with Advanced Hematological Malignancies." . : 299
November 2005 Cashen A, Devine S, Ravi V, DiPersion J.."AMD3100+G-CSF Improves Hematopoietic Progenitor Cell (HPC) Collection in Patients with Hodgkin's Disease (HD)." . : 1979
November 2005 Andritsos L, Augustin K, Ravi V, DiPersio JF, Devine SM.."Acute GVHD May Play a Role in Preventing Relapse Following Reduced Intensity Allografts for Acute Myeloid Leukemia." . : 1807
February 2005 Uy GL, Fisher NM, Devine SM, Adkins DR, Tomasson MH, Graubert TA, DiPersio JF, Vij R.."Bortezomib does not adversely affect stem cell mobilization and engraftment in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplantation." . : 77
February 2005 Andritsos LA, Edwards T, Sempek D, Calandra G, Badel K, Vij R, DiPersio JF, Devine SM.."A pilot study evaluating the safety and efficacy of AMD3100 for the mobilization and transplantation of HLA-matched sibling donor hematopoietic stem cells in patients with advanced hematological malignancies." . : 5
November 2006 Devine SM, Ravi V, Todt L, McLaughlin K, Fisher N, Morris N, Link DC, Calandra G, Bridger G, DiPersion JF.."HLA-Matched Sibling Donor Stem Cell Mobilization Can be Safecly and Effectively reduced from a Five Day to a One Day Process by a Direct antagonist of the CXCR4/SDF-1 Interaction." . : 53
November 2006 Crawford RD, Krugh D, Blum W, Devine S.."Transplantation without Hemolysis in a Kell Antigen Positive Patient Undergoing Peripheral Hematopoietic Stem Cell Transplant from a Donor with Anti-Kell Antibodies." . : 4137
November 2006 Bashey A, Owzar K, Johnson JL, Devine SM, Shadduck RK, Shea TC, Linker C.."Reduced-Intensity Allogeneic Transplantation after Failure of Autologous Transplantation: A Prospective Multi-Center CALGB Study." . : 3122
February 2006 Tiward D, Vij R, Devine S, DiPersio J, Khoury HJ.."Does GM-CSF alter the prognostic significance of early lymphocyte recovery post-autografting for NHL?" . : 99
February 2006 Devine SM, Todt L, Bonde J, Hess D, Devine H, Nolta J, Link D, Calandra G, Bridger G, DiPersio JF.."A pilot study evaluating the safety and efficacy of AMD3100 for the mobilization and transplantation of HLA-matched sibling donor hematopoietic stem cells in patients with advanced hematological malignancies." . : 35
February 2006 Cashen AF, Devine S, Vij R, DiPersio J.."AMD3100 + G-CSF improves hematopoietic progenitor cell (HPC) collection in patients with hodgkin's disease (HD)." . : 92
November 2006 Rettig M, Devine SM, Ritchey J, DiPersio JF.."Phenotypic and Functional Analysis of T-Cells Mobilized in HLA-Matched Sibling Donors Following Treatment with the Chemokine Antagonist AMD3100." . : 3001
November 2006 Reddy V, Vaughan W, Devine S, Rowley SD, Wallker N, Devetten M, Schiller GJ.."A Pilot Trial of Two dose Levels of Rabbit Antithymocyte Globulin, (rATG), Thymoglobulin as Part of a Myeloablative-Conditioning for a HLA Identical Matched Related Donor Stem Cell transplant (SCT) with Cyclosporine (CsA) as Grant Versus Host Disease ...." . : 5369
November 2007 Hamadani M, Elder P, Awan F, Krugh D, Blum W, Lin T, Andritsos L, Bechtel T, Blum K, Klisovic R, Devine SM.."High Rates of Early Donor Chimerism and Low Risk of Chronic GVHD Can Be Achieved in Poor Risk Patients Undergoing Unrelated Donor Stem Cell Transplantation Using a Reduced Intensity Conditioning regimen Incorporating Fludarabine, busulfan and Rabbit ATG." . : 5080
November 2007 Hamadani M, Awan F, elder P, Porcu P, Lin T, Blum K, Scholl D, Devine SM.."Allogeneic Hematopoietic Stem Cell Transplantation for peripheral T-Cell Lymphoma: Evidence of Granft-Versus-Lymphoma Effect." . : 3044
November 2007 Andritsos L, Hamadani M, Heerema NA, Benson D, Hofmeister CC, Blum W, Flynn J, Jones JA, Elder P, Lin TS, Lozanski G, Byrd JC, Devine S.."Attainmnet of Minimal Residual Disease negative State Is Crucial for Successful Outcome of Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation in Advanced Chronic Lymphocytic Leukemia (CLL)." . : 2170
February 2007 Rice JM, Sirilla JA, Krugh DW, Crawford R, Benson DM, Devine SM.."404: Surveillance, evaluation and management of passenger lymphocyte syndrome." . : 145
February 2008 Hamadani M, Phillips G, Elder P, Jansak B, Blum W, Penza S, Lin TS, Farag SS, Devine SM.."356: Phase-II Study of Infliximab for the Prophylaxis of Acute Graft-Versus-Host Disease (GVHD) Following Allogeneic Hematopoietic Stem Cell Transplantation (AHSCT)." . : 130
February 2008 Hamadani M, Awan FT, Elder P, Lin TS, Andritsos L, Blum W, Blum KA, Devine SM.."310: Rapid Engraftment and Low Rates of Grast-versus-host Disease (GVHD) Following Reduced Intensity Conditioning (RIC) with Fludarabine/Busulfan/ATG (FBA) and Stem Cell Transplantation (SCT) using Unrelated Donors (URD)" . : 114
February 2008 Bechtel TP, Crawford BS, Gordon SM, Penza S, Hofmeister C, Benson D, Devine S.."471: An aprepitant containing Regimen Controls the Delayed Nausea and vomiting Associated with High-dose Melphalan followed by autologous Peripheral Blood Stem Cell Transplantation in Patients with Multiple Myloma." . : 166
November 2008 Hamadani M, Blum W, Benson D, Blum KA, Porcu P, Elder P, Krugh D, Bechtel T, Andritsos L, Garzon R, Penza S, Lin TS, Devine SM.."Assessment of Rabbit Antithymocyte Globulin (rATG) Dose-Intensity in Patients with Hematological Malignancies Undergoing Allogeneic Stem Cell Transplantation (ASCT) Following Reduced Intensity Conditioning (RIC) with Fludarabine, Busultan and rATG (FBA)." . : 4405
November 2008 Hamadani M, Blum KA, Elder P, Lin TS, Porcu P, Hofmeister C, Blum W, Marcucci G, Benson D, Devine S.."Allogeneic Stem Cell Transplantation for Patients with Chemo-Refractory of Progressive Aggressive Non-Hodgkin's Lymphomas." . : 3265
November 2008 Blum W, Klisovic R, Liu S, Garzon R, Kefauver C, Liu Z, Mickle J, Devine H, Devine S, Grever MR, Chan KK, Villalona-Calero M, Byrd JC, Marcucci G.."Preliminary Results of a Phase II Study of Low Dose Decitabine as a Single" . : 2957
November 2008 Blum KA, Liu Z, Lucas DM, Baiocchi R, Lin TE, Benson D, Devine SM, Jones J, Andritsos L, Flynn JM, Cheng P, Xie Z, Marcucci G, Chan KK, Grever MR, Byrd JC.."A Phase I Evaluation of Low Dose Decitabine Targeting DNA Hypermethylation in Patients with Chronic Lymphocytic Leukemia (CLL) and Non-Hodgkin's Lymphoma (NHL):Dose-Limiting Myelosuppression without Evidence of Hypomethylation." . : 3169
November 2008 Benson D, Andritsos L, Hamadani M, Lin T, Flynn J, Jones J, Blum W, Elder P, Lozanski G, Byrd J, Devine S.."Natural Killer Cell Immune Reconstitution Predicts Outcomes for Patients with Chronic Lymphocytic Leukemia Undergoing Allogeneic Stem Cell Transplantation." . : 3300
November 2009 Devine SM, Soiffer RJ, Pasquini MC, Carter S, Hari PN, DeVore S, Stein A, Lazarus HM, Linder C, Stadtmauer EA, Keever-Taylor CA, O'Reilly RJ.."HLA-Identical Sibling-Matched, CD235+ Selected, T Cell Depleted Peripheral Blood Stem Cells Following Myeloablative Conditioning for First or Second Remission Acute Myeloid Leukemia (AML): Results of Blood and Marrow transplant Clinical Trials Network (BM" . : 655
November 2009 Blum W, Klisovic RB, Walker A, Garzon R, Liu S, Schaaf LJ, Humphries K, Grever MR, Devine S, Byrd JC, Marcucci G.."Methyltransferase: A Phase I Study of Bortezomib in Combination with 5-Azacytidine in Adults with Relapsed or Refractory Acute Myeloid Leukemia (AML)." . : 2065
November 2009 Jaglowski SM, Lin TS, Elder P, Scholl D, Byrd JC, Devine SM.."Barriers to Reduced-Intensity Conditioning (RIC) Transplant in Patients with Chronic Lymphocytic Leukemia." . : 1374
November 2009 Farag S, Owzar K, Hars V, Lazarus HM, Stadtmauer EA, Devine SM, van Besien K, Linker C.."A Prospective Multicenter Phase II Trial of Pentostatin in Adult patients with Steroid-Refractory Chronic Graft-Versus-Host Disease (cGVHDD): A Cancer and Leukemia Group b/Eastern Cooperative Oncology Group Study." . : 2238
November 2009 Chandler JC, Klisovic RB, Phelps MA, Walker A, Garzon R, Yang X, Schaaf L, Schwind S, Becker, Liu S, Hickey C, Kefauver C, Mickle J, Devine SM, Grever MR, Byrd JC, Marcucci G, Blum W.."Phase I Study of Lenalidomide in Acute Leukemia: Remissions in Post-Allogeneic Relapse of Acute Myeloid Leukemia." . : 841
November 2009 Blum W, Klisovic RB, Walker A, Garzon R, Liu S, Schaaf LJ, Humphries K, Grever MR, Devine SM, Byrd JC, Marcucci G.."Epigenetic Targeting Via Transcriptional Inhibition of DNA Methyltransferase: a Phase I Study of Bortezomib in Combination with 5-Azacytidine in Adults with Relapsed or Refractory Acute Myeloid Leukemia (AML)." . : 2065
November 2009 Benson D, Bakan CE, Alghothani L, Hofmeister CC, Efebera YA, Smith MK. Greenfield CN, Andre P, Squiban P, Romagne F, Caligiuri MA, Devine SM.."Characterization of Early Natural Killer Cell Reconstitution following autologous transplantation in Multipe Myeloma." . : 4641
February 2009 Hamadani M, Benson DM, Porcu P, Elder P, Andritsos L, Hofmeister CC, Krugh D, Garzon R, Lin T, Marcucci G, Blum W, Devine SM.."Evaluation of Rabbit Antithymocyte Globulin (rATG) Dose-intensity in Patients Undergoing Allogeneic Stem Cell transplantation (ASCT) Following Reduced Intensity conditioning (RIC) with Fludarabine, Busulfan and rATG (FBA)." . : 5
February 2009 Hamadani M, Baiocchi R, Lin T, Blum KA, Ezzone S, Benson DM, Devine SM.."Feasibility of Allogeneic peripheral Blood stem Cell Transplantation (Allo-SCT) Following reduced Intensity Conditioning (RIC) in HIV+ Patients with Hematological Malignancies." . : 113
February 2009 Grauer A, Hamadani M, Blum KA, Porcu P, Benson DM, Devine SM.."Allogeneic Versus Autologous Stem Cell Transplantation (SCT) for Follicular Lymphoma (FL). The James Comprehensive Cancer Center Experience." . : 132
February 2009 Benson DM, Hofmeister CC, Hamadani M, Panzner K, Smith MK, Penza SL, Elder P, Krugh D, O'Donnell L, Devine SM.."Pre-Mobilization Bone Marrow Plasmacytosis Predicts Successful Stem Cell Mobilization in Patients with Multiple Myeloma Receiving Lenalidomide-Based Induction regimens." . : 67
February 2009 Bechtel TP, Devine S."Use of a Calcium/Phosphate Oral Rinse (Caphosol®) to Lessen the Mucositis Following Autologous Peripheral Blood Stem Cell Transplantation." . : 154
November 2009 Rotem-Yehudar R, Armand P, Devine S, Fay JW, Hosing C, Mapara MY, Campagnero E, Uberti JP, Avigan D, Ballen KK, Winter JN, Nagler A, Gordon LI.."The Humanized Anti PD-1 Antibody, CT-001, Increases specific CD4+Effector/Memory and Memory T Lymphocytes in Patients with Diffuse Large B Cell Lymphoma (DLBCL) Following Autologous Stem Cell transplantation (AuSCT)." . : 1216
November 2009 Mahindra A, Bolwell BJ, Dean R, Kalaycio M, Avalos B, Rybicki L, Tench S, Elder P, Sobecks R, Sweetenha J, Pohlman B, Andresen S, Devine S, Copelan E.."Etoposide Priming in Patients with Lymphoma Improves Mobilization without An Increased Risk of Secondary Hematologic Malignancies." . : 2264
January 2010 Jaglowski SM, Flynn JM, Jones JA, Lin TS, Fischer B, Scholl D, Elder P, Devine S, Grever MR, Byrd JC, Andritsos LA.."Flavopiridol is an Effective Therapy to Bridge Patients with Chronic Lymphocytic Leukemia (CLL) to Reduced-Intensity Conditioning Allogeneic Stem Cell Transplant." Orlando. : 987
January 2010 Hofmeister CC, Rieser G, Bowers MA, Merritt LC, Greenfield CN, Efebera YA, Benson DM Jr, Devine S, de Moor JS.."Tablet-Based Assessment of Fatigue, Depression and Pain in Myeloma Patients: Cohort Study of Inflammatory Cytokines and QOL Measures in the Newly Diagnosed, Patients on Lenalidomide and Survivors." Orlando. : 1557
January 2010 Blum W, Klisovic RB, Garzon R, Walker A, Schwind S, Liu S, Schaaf L, Garr C, Devine S, Grever MR, Byrd JC, Marcucci G.."A Phase 1 Trial of decitabine and Bortezomib in High Risk Acute Myeloid Anemia (AML)" Orlando. : 1349
January 2010 Armand P, Perez W, Zhang MJ, Kim H, Klumpp TR, Dal Cin P, Walker EK, Litzow MR, Liesveld JL, Lazarus HM, Artz A, Gupta V, Savani BN, McCarthy PL, Cahn JY, Schouten H, Finke J, Ball ED, Aljiurf M, Cutler C, Rowe JM, Antin JH, Isola LM, Di Bartholomeo P, Camitta B, Miller AM, Cairo MS, Stockerl-Goldstein KE, Sierra J, Savoie ML, Halter J, Stiff PJ, Nabhan C, Jakubowski AA, Bunjes D, Petersdorf EW, Devine S, Maziara R, Bornhauser M, Lewis VA, Marks DI, Bredeson CN, Soiffer R, Weisdorf DJ.."Cytogenetics Abnormalities Predict the Outcome of Allogeneic Transplantation in AML: A CIBMTR Study." Orlando. : 299
December 2010 Stauffer N, Hamadani SM, Heaphy C, Santhanam R, Sandhu S, Costinean S, Nuovo J, Perrotti D, Croce CM, Hadley G, Marcucci S, Devine S, Garzon R.."Regulation of Acute Graft-Versus-Host Disease by Micro RNA-155." Orlando. : 113
December 2010 Soiffer RJ, LeRademacher J, Ho VT, Kan F, Artz A, Champlin R, Devine S, Lazarus HM, Marks DI, Porter D, Waller EK, Horowitz MM, Eapen.."Impact of In Vivo T-Cell Depletion on Outcome of Reduced Intensity Conditioning (RIC) Hematopoietic Cell Transplantation (HCT) for Hematologic Malignancies Impact of In Vivo T-Cell Depletion on Outcome of Reduced Intensity Conditioning (RIC) Hematopoietic Cell Transplantation (HCT) for Hematologic Malignancies." Orlando. : 951
December 2010 Habis J, Dunavin N, Philips G, Elder P, Tranovich M, Benson DM Jr, Hofmeister CC, Byrd JC, Devine S, Efebera Y.."Analysis of 179 Patients with newly diagnosed Multiple Myeloma (MM) Treated with Novel Agents followed by autologous Stem Cell transplantation (ASCT): a Retrospective Study" Orlando. : 575
November 2012 Devine S, Owzar K, Blum W, DeAngelo D, Stone RM, Hsu JW, Champlin RE, Chen YA, Vij R, Slack JL, Soiffer RJ, Larson RA, Shea TC, Hars V, Bennett E, Spangle S, Giralt SA, Carter SL, Horowitz MM, Linker C, Alyea EP.."A Phase II Study of Allogeneic Transplantation for Older Patients with AML in First Complete Remission Using a Reduced Intensity Conditioning Regimen: Results from CALGB 100103/BMT CTN 05802" n/a.

Presentations

"Stem Cell Plasticity." Presented at NMDP Council Meeting, . (November 2002)

"Mesenchymal Stem cell Transplantation." Presented at American Society for Apheresis Meeting, . (May 2002)

"Advances in Allogeneic Stem Cell Transplantation." Presented at Marilyn Fixman Lecture, Barnes-Jewish Hospital, . (December 2002)

"Mesenchymal Stem Cell Transplantation." Presented at Cook County Hospital Medical Grand Rounds, Chicago, IL. (April 2002)

"Advances in Allogeneic Stem Cell Transplantation." Presented at Medical Grand Round, Washington University, St. Louis, MO. (April 2002)

"Advances in Allogeneic Transplantation." Presented at Advances in Oncology Lecture Series, Chicago, IL. (January 2003)

"Hematological Malignancies." Presented at American Society of Hematology Review, . (February 2003)

"Graft Versus Host Disease." Presented at University of Missouri Hematology Grand Rounds, St. Louis, MO. (June 2004)

"Hematological Malignancies." Presented at American Society of Clinical Oncology Review, St. Louis, MO. (July 2004)

"Pulmonary Complications of Stem Cell Transplantation." Presented at Pulmonary Grand Rounds, Washington University, St. Louis, MO. (September 2004)

"Ethics of Stem Cell Research." Presented at Washington University Ethics Forum, St. Louis, MO. (September 2004)

"Advances in Allogeneic Stem Cell Transplantation." Presented at Medical Grand Rounds, Washington University, St. Louis, MO. (December 2004)

"Advances in Allogeneic Stem Cell Transplantation." Presented at Radiation Oncology Grand Rounds, Columbus, OH. (January 2004)

"Stem Cell Transplantation of Acute Myeloid Leukemia." Presented at Hematology Grand Rounds, Carle Clinic, Urbana, IL. (April 2005)

"Mobilized Blood Cells for Allogeneic Transplantation." Presented at American Association of Blood Banks Audioconference, . (April 2005)

"Improving Stem Cell Mobilization by CXCR4 Antagonism." Presented at University of Alberta BMT Grand Rounds, Calgary, AB, CA|CAN. (April 2005)

"Improving Stem Cell Mobilization by CXCR4 Antagonism." Presented at University of British Columbia BMT Grand Rounds, Vancouver, BC, CA|CAN. (April 2005)

"Mobilization of Allogeneic Stem Cells." Presented at University of Florida BMT Grand Rounds, . (May 2005)

"Stem Cell Mobilization." Presented at ASBMT/CIBMTR Annual Meeting, Keystone, CO. (February 2005)

"Mobilization of Hematopoietic Stem Cells in Normal Volunteers." Presented at National Marrow Donor Program Council Meeting, . (November 2005)

"Stem Cell Transplantation." Presented at American Society of Hematology Review, St. Louis, MO. (July 2005)

"Stem Cell Transplantation." Presented at American Society of Clinical Oncology Review, St. Louis, MO. (July 2005)

"Improving Stem Cell Mobilization by CXCR4 Antagonism." Presented at Medical College of Wisconsin BMT Grand Rounds, Milwaukee, WI. (July 2005)

"Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia." Presented at Radiation Oncology Fellowship Training Lecture, Columbus, OH. (August 2005)

"Novel methods of stem cell mobilization." Presented at Cincinnati Childrens Hospital, . (December 2005)

"Fungal infections in recipients of blood and marrow transplant." Presented at American Society of Hematology Super Friday Symposium, . (December 2005)

"A pilot study evaluating the safety and efficacy of AMD3100 for the mobilization and transplantation of HLA-matched sibling donore hematopoietics stem cells in patients with advanced hematological maligancies.." Presented at American Society of Hematology Annual Meeting, Atlanta, GA. (December 2005)

"Poster: A pilot study evaluating the safety and efficacy of AMD3100 for the mobilization and transplantation of HLA-matched sibling donor hematopoietics stem cells in patients with advanced hematological malignancies." Presented at ASBMT Tandem Meeting, Honolulu, HI. (February 2006)

"Advances in the treatment of chronic myeloid leukemia." Presented at Oncology Best Practices 2006, . (February 2006)

"A pilot study evaluating the safety and efficacy of AMD3100 for the mobilization and transplantation of HLA-matched sibling donor hematopoietics stem cells in patients with advanced hematological malignancies." Presented at American Society of Hematology Annual Meeting, Honolulu, HI. (February 2006)

"Current approaches to treating acute myeloid leukemia (AML) in the elderly." Presented at Bucyrus Community Hospital Medical Staff, . (August 2006)

"Current approaches to treating acute myeloid leukemia (AML) in the elderly." Presented at Wyandot Memorial Tumor Board, . (August 2006)

"Advances in allogenic transplantation." Presented at Ohio State University Medical Center Fellows Lecture, . (October 2006)

"Improving stem cell mobilization by targeting CXCR4." Presented at American Society of Hematology Super Friday Symposium, . (December 2006)

"Allogeneic hematopoietic cell transplantation for acute myeloid leukemia (AML)." Presented at Ohio State University Comprehensive Cancer Center Grand Rounds, . (December 2006)

"Advances in allogenic transplantation." Presented at Ohio State University Medical Center Resident lecture series, . (December 2006)

"Recent advances in treatment of acute myeloid leukemia." Presented at Columbus Chapter of the Oncology Nursing Society, . (April 2006)

"Improving stem cell mobilization by CXCR4 antagonism." Presented at Moffit Cancer Center BMT Grand Rounds, Tampa, FL. (April 2006)

"Stem cell transplantation." Presented at Annual American Society of Hematology Review Meeting, Columbus, OH. (May 2006)

"Improving stem cell mobilization by targeting CXCR4." Presented at University of Pennsylvania Medical Center AnorMed Dinner Program, State College, PA. (June 2006)

"Improving stem cell mobilization by targeting CXCR4." Presented at Yale University School of Medicine Round Table Dinner, New Haven, CT. (September 2006)

"Update in CML management." Presented at Novarits Dinner Program, Columbus, OH. (November 2006)

"Update in CML management." Presented at Novarits Dinner Program, Barboursville, WVA. (November 2006)

"Advances in allogenic stem cell transplantation." Presented at Bone Marrow Transplantation Series, . (November 2006)

"Treatment of AML in elderly patients." Presented at Ohio State University Medical Center Pathology Grand Rounds, . (March 2006)

"Recent development in acute myeloid leukemia." Presented at Chillicothe VA Lecture, . (July 2006)

"T-depleted transplant for AML." Presented at BMT CTN Steering Committee Meeting, . (July 2006)

"Recent developments in allogeneic hematopoietic stem cell transplantation." Presented at Piedmont Oncology Association Program Committee, Wake Forest University, Myrtle Beach, SC. (October 2007)

"Treatment of myeloid malignancies." Presented at Update on treatment of hematological treatment, . (February 2007)

"HLA-matched sibling donor stem cell mobilization can be safely and effectively reduced from a five day to a one day process by a direct antagonist of the CXCR4/SDF-1 interaction." Presented at BMT Tandem Meeting, Keystone, CO. (February 2007)

"CXCR4 antagonist to enhance stem cell mobilization." Presented at Genzyme Advisory Board, Boston, MA. (February 2007)

"Update on CML management." Presented at Novartis Dinner Program, Charleston, WVA. (April 2007)

"CXCR4 antagonist to enhance stem cell mobilization." Presented at Midwest Blood Club Meeting-Cincinnati Childrens Hospital, Cincinnati, OH. (April 2007)

"Update on CML Management." Presented at Ohio State University Comprehensive Cancer Center Hem/Onc Review, Charleston, WVA. (June 2007)

"Allogeneic stem cell transplantation for hematologic malignancies." Presented at Genesis Health Care System, Good Samaritan Hospital Tumor Board, Zanesville, OH. (August 2007)

"Current and potential therapeutic applications of AMD3100." Presented at A. G. Edwards Dinner, Boston, MA. (May 2007)

"Allogeneic cell transplantation for acute myeloid leukemia." Presented at Ohio State University Comprehensive Transplant Program Conference, Columbus, OH. (May 2007)

"Hematopoietic stem cell transplantation in myeloidysplastic syndrome." Presented at The Leukemia & Lymphoma Society MDS Program, Columbus, OH. (January 2008)

"Update on stem cell mobilization for patients and donors." Presented at ISCT 2nd Annual Regional Meeting, Columbus, OH. (April 2008)

"Novel applications of the CXCR4 antagonist plerixafor." Presented at European Bone Marrow Transplant Symposium, Florence, IT|ITA. (April 2008)

"New Mobilization Approaches in Allogeneic Transplantation." Presented at Genzyme Symposium "Optimising Patients Outcomes in Haematology", Berlin, DE|DEU. (October 2008)

"Update on CML management." Presented at Novartis CML Program, Roanoke, VA. (May 2008)

"A single arm multi-center phase II trial of transplants of HLA-matched, CD34+ enriched, T-cell depleted peripheral blood stem cells isolated by the CliniMACS system in the treatment of patients with AML in first or second complete remission.." Presented at ISCT 2008 Meeting, Miami, FL. (May 2008)

"Update on stem cell mobilization for patients and donors." Presented at BMT Tandem Meeting-Pharmacist Symposium, San Diego, CA. (February 2008)

"Advances in stem cell mobilization for patients and donors." Presented at BMT Tandem Meeting-ASBMT Noon Symposium, San Diego, CA. (February 2008)

"Influence of graft content on outcomes in autologous and allogeneic transplantation." Presented at ISCT 2nd Regional Meeting, Columbus, Ohio. (April 2008)

"New Approaches to Stem Cell Mobilization." Presented at Canadian Apheresis Group Annual Meeting, Ottawa, ON, CA|CAN. (May 2009)

"Frontline Treatment for Multiple Myeloma: Current Options for Initial Therapy.." Presented at New York Oncology Hematology and Oncology Today, Chicago, IL. (May 2009)

"Reduced intensity allogeneic transplantation in patients with myeloid diseases: are we making progress?." Presented at CIBMTR-ASBMT Tandem BMT Meetings, Satellite Symposium, Tampa, FL. (February 2009)

"Recent Developments in Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia.." Presented at New York Presbyterian Hospital Special Hematology Seminar, New York, NY. (February 2009)

"Improving Stem Cell Mobilization by Targeting CXCR4." Presented at Update on Allogeneic Hematopoietic Cell Transplantation, AABB Audioconference, Columbus, OH. (April 2009)

"Treating special populations of patients with multiple myeloma.." Presented at Kettering Hospital Educational Forum, Dayton, OH. (November 2009)

"Improving Outcomes of Allogeneic transplantation in Patients with Acute Leukemia.." Presented at Case Western Blood Club, Cleveland, OH. (October 2009)

"Allogeneic Hematopoietic Cell Transplantation for cutaneous Lymphoma." Presented at Cutaneous Lymphoma Summit Meeting, New York, NY. (October 2009)

"Can we Define Reduced Intensity Conditioning?." Presented at Otsuka Busulfan Investigator's Summit, SG|SGP. (March 2009)

"Improving stem cell mobilization outcomes.." Presented at Duke University Medical Center Grand Rounds, Chapel Hill, NC. (August 2010)

"T-cell depleted transplantation for AML." Presented at International Society of Cellular Therapy Meeting: Miltenyi Seminar, Philadelphia, PA. (May 2010)

"Frontline Treatment for Multiple Myeloma: Current Options for Initial Therapy"." Presented at New York Oncology Hematology and Oncology Today, Chicago, IL. (May 2010)

"Improving stem cell mobilization outcomes.." Presented at University of Nebraska Medical Center Grand Rounds, Omaha, NE. (September 2010)

"Defibrotide (DF) in the Treatment of Severe Hepatic Veno-Occlusive Disease (VOD) with Multi-Organ Failure (MOF)L Results of a Treatment IND Expajded Access Protocol." Orlando, FL. (December 2010)

"Can blood cell transplantation be improved by modifying the mobilization regimen?." Presented at Dana-Farber Cancer Institute Grand Rounds, Boston, MA. (October 2010)

"Overcoming Challenges and Examining Opportunities in Improving Stem Cell Mobilization Outcomes." Presented at Grand Rounds, Boston, MA. (April 2011)

"Hematopoietic Stem Cell Transplantation." Presented at Highlights of ASH, Washington, DC. (January 2011)

"Thymoglobulin in HSCT: OSU and CALGB Experience." Presented at BMT Tandem Meetings, Honolulu, HI. (February 2011)

"Hematopoietic Stem Cell Transplantation." Presented at Highlights of ASH, San Diego, CA. (February 2011)

"Role of Maintenance Therapy in Multiple Myeloma." Presented at NCCN 6th Annual Congress, New York, NY. (September 2011)

"Clinical Allogeneic and Autologous Transplantation - Results: Novem Regimes and Prognostic Scoring." Presented at 53rd ASH Annual Meeting and Exposition, San Diego. (December 2011)

"N/A." Presented at Asia Pacific Transplant and Hematology Forum, Taipei, TW|TWN. (May 2012)

"S-O-A-B Oral Abstracts Session B - Autologous." Presented at ASBMT/CIBMTR Tandem Meetings, San Diego. (February 2012)

"GVHD Prevention thru T-Cell Depletion: What have we learned?." Presented at ASBMT/CIBMTR Tandem Meetings, San Diego. (February 2012)

"N/A." Presented at West Virginia University Hospital Grand Rounds, Morgantown. (January 2012)

"ADMIN-12 Cost Savings Measures through Collaboration." Presented at BMT Center Administrators Conference, San Diego. (February 2013)

"Transplantation for older patients with AML: who benefits?." Presented at Case Western Reserve University, Cleveland. (March 2013)

"Update on Bone Marrow Transplantation for Turkish Hematologists." Presented at Post Tandem Transplant Symposium, Ankara, TR|TUR. (March 2013)

 

Professional Activities

2002 - present NMDP Meeting. National Marrow Donor Program. Minneapolis, MN.
2002 - present Marilyn Fixman Lecture. Barnes-Jewish Hospital. St. Louis, MO.
2002 - present Medical Grand Rounds. Washington University. St. Louis, MO.
2002 - present Cook County Hospital Medical Grand Rounds. Cook County Hospital. Chicago, IL.
2003 - present American Society of Hematology Review. Washington University. St. Louis, MO.
2004 - present American Society of Clinical Oncology Review. American Society of Clinical Oncology. St. Louis, MO.
2004 - present Washington University Ethics Forum. Washington University. St. Louis, MO.
2004 - present Pulmonary Grand Rounds. Washington University. St. Louis, MO.
2004 - present University of Missouri Hematology Grand Rounds. University of Missouri. St. Louis, MO.
2004 - present Medical Grand Rounds. Washington University. St. Louis, MO.
2005 - present American Society of Hematology Super Friday Symposium. American Society of Hematology. Atlanta, GA.
2005 - present American Society of Hematology Meeting. American Society of Hematology. Atlanta, GA.
2005 - present Cincinnati Childrens Hospital Grand Rounds. Cincinnati Childrens Hospital. Cincinnati, OH.
2005 - present University of British Columbia BMT Grand Rounds. Improving Stem Cell Mobilization by CXCR4 Antagonism. Vancouver, BC.
2005 - present University of Alberta BMT Grand Rounds. University of Alberta. Calgary, AB.
2005 - present American Association of Blood Banks Audioconference. American Association of Blood Banks. Columbus, OH.
2005 - present University of Florida BMT Grand Rounds. University of Florida. Gainesville, FL.
2005 - present Medical College of Wisconsin BMT Grand Rounds. Medical College of Wisconsin. Milwaukee, WI.
2005 - present American Society of Clinical Oncology Review. American Society of Clinical Oncology. St. Louis, MO.
2005 - present ASBMT/CIBMTR Annual Meeting. ASBMT/CIBMTR. Keystone, CO.
2005 - present 2005 Berlex Medical Affairs Meeting. Berlex, Inc.. St. Louis, MO.
2005 - present National Marrow Donor Program Council Meeting. National Marrow Donor Program. Minneapolis, MN.
2005 - present American Society of Hematology Review. American Society of Hematology. St. Louis, MO.
2005 - present Hematology Grand Rounds. Carle Clinic. Urbana, IL.
2006 - present Anormed Dinner Program. University of Pennsylvania Medical Center. Philadelphia, PA.
2006 - present Chillicothe VA Lecture. VA Hospital. Chillicothe, OH.
2006 - present BMT CTN Steering Committee Meeting. BMT CTN. Minneapolis, MN.
2006 - present Wyandott Memorial Tumor Board. Wyandott Memorial Hospital. Upper Sandusky, OH.
2006 - present Bucyrus Community Hospital Medical Staff. Bucyrus Community Hospital. Bucyrus, OH.
2006 - present Round Table Dinner. Yale University School of Medicine. New Haven, CT.
2006 - present Pathology Grand Rounds. The Ohio State University Medical Center. Columbus, OH.
2006 - present Fellows Lecture. The Ohio State University Medical Center. Columbus, OH.
2006 - present Novartis Dinner Program. Novartis. Barbourville, WV.
2006 - present Novartis Dinner Program. Novartis. Columbus, OH.
2006 - present Columbus Chapter of the Oncology Nursing Society. Recent advances in treatment of acute myeloid leukemia. Columbus, OH.
2006 - present BMT Grand Rounds. Moffit Cancer Center. Tampa, FL.
2006 - present Annual American Society of Hematology Review Meeting. American Society of Hematology. Columbus, OH.
2006 - present American Society of Hematology Meeting. American Society of Hematology. Orlando, FL.
2006 - present Oncology Best Practices 2006. The Ohio State University. Columbus, OH.
2006 - present ASBMT Tandem Meeting. ASBMT. Honolulu, HI.
2006 - present Bone Marrow Transplantation Series. The Ohio State University. Columbus, OH.
2006 - present Super Friday Symposium. American Society of Hematology. Orlando, FL.
2007 - present Novartis Dinner Program. Novartis. Charleston, WV.
2007 - present Midwest Blood Club Meeting. Midwest Blood Club. Cincinnati, OH.
2007 - present Good Samaritan Hospital Tumor Board. Genesis Health Care System. Zanesville, OH.
2007 - present A.G. Edwards Dinner. Boston, MA.
2007 - present Ohio State University Comprehensive Cancer Center Hem/Onc Review. Update on CML Management. Columbus, OH.
2007 - present Piedmont Oncology Association Program Committee. Wake Forest University. Myrtle Beach, SC.
2007 - present Genzyme Advisory Board. Genzyme. Boston, MA.
2007 - present Genzyme Advisory Board. Genzyme.
2007 - present BMT Tandem Meeting. ASBMT Tandem Meetings. Keystone, CO.
2007 - present Update on Treatment of Hematological Treatment. The Ohio State University. Columbus, OH.
2007 - present Ohio State University Comprehensive Transplant Program Conference. The Ohio State University. Columbus, OH.
2008 - present 2008 BMT Tandem Meeting. ASBMT. San Diego, CA.
2008 - present ISCT 2008 Meeting. International Society for Cellular Coverage. Miami, FL.
2008 - present ISCT 2nd Regional Meeting. International Society for Cellular Therapy. Columbus, OH.
2009 - present Canadian Apheresit Group Annual Meeting. Canadian Apheresis Group. Ottawa, ON.
2009 - present Satellite Symposium. National Marrow Donor Program. New Orleans, LA.
2009 - present Cutaneous Lymphoma Summit Meeting. New York City, NY.
2009 - present Case Western Blood Club. Ireland Cancer Center. Cleveland, OH.
2009 - present Satellite Symposium. CIBMTR-ASBMT Tandem BMT Meetings. Tampa, FL.
2009 - present Audioconference, Update on Allogeneic Hematopoietic Cell Transplantation. AABB. Columbus, OH.
2010 - present CALGB Fall Meeting. Cancer & Leukemia Group B Clinical Research Group. Chicago, IL.
2010 - present BMT/CTN Steering Committee Meeting. Blood and Marrow Transplant Clinical Trials Network. Arlington, VA.
2010 - present Data Patient Safety Monitoring Meeting. National Marrow Donor Program. Minneapolis, MN.
2010 - present Blood and Marrow Transplant Clinical Trials Myeloma Intergroup Meeting. Blooc and Marrow Transplant Clinical Trials Network. Minneapolis, MN.
2010 - present Genzyme Ad Board Meeting. Genzyme. Orlando, FL.
2010 - present CALGB 2010 Spring Meeting. Cancer & Leukemia Group B Clinical Research Group. Raleigh, NC.
2011 - present CALGB Fall Group Meeting. Cancer & Leukemia Group B Clinical Research Group. Miami, FL.
2011 - present Satellite Cymposium. Kiadis Pharma.
2011 - present Engraftment Study Discussiong. GlaxoSmithKline. Boston, MA.
2011 - present DPSM Committee Meeting. National Marrow Donor Program. Minneapolis, MN.
2011 - present Investigator Update: ASH 2010. Genzyme Transplant Oncology.
2011 - present Genzyme Advisory Board Meeting/Thymoglobulin in Hematopoietic Stem Cell Transplantation. Genzyme. Honolulu, HI.
2011 - present
2011 - present CALGB Board of Directors Meeting. Cancer & Leukemia Group B Clinical Research Group. Chicago, IL.
2002 American Society for Apheresis Meeting. Orlando, FL.
2008 European Bone Marrow Transplant Symposium.
2008 The Leukemia & Lymphoma Society MDS Program. The Leukemia & Lymphoma Society. Columbus, OH.
2009 51st ASH Annual Meeting and Exposition. American Society of Hematology. New Orleans, LA.
2010 BMT Tandem Meetings. ASBMT/CIBMTR. Orlando, FL.
2010 52nd ASH Annual Meeting and Exposition. American Society of Hematology. Orlando, FL.
2011 2011 BMT Tandem Meetings. ASBMT/CIBMTR. Honolulu, HI.
2011 Macroglobulinemia Panel Annual Guidelines Update Meeting. National Comprehensive Cancer Network. Philadelphia, PA.
2011 ASCO 11th Annual Meeting. American Society of Clinical Oncology. Chicago, IL.
2011 37th Annual European Group for Blood and Marrow Transplantation. EBMT.
2011 CALGB Spring Meeting. Cancer & Leukemia Group B Clinical Research Group. Chicago, IL.